Submit a Manuscript
Search Articles
F6Publishing
Publisher Login
Manuscript Statistics
Articles In Press
1
Varatharajan S, Krishnasai S, Girish C. Human immunodeficiency virus vaccines: Advances, challenges and future perspectives. World J Virol 2026; In press
2026-02-11 | Browse: 9 | Download: 0
2
Ravi PK, Rout S, Mishra PR, Balamurugan AN. Influence of islet purity on the proportion of smaller islets and graft outcomes in clinical transplantation. World J Transplant 2026; In press
2026-02-11 | Browse: 4 | Download: 0
3
Zubair RA, Zhou XH, Fabi SG. Adipose-derived stem cell stimulation using poly-L-lactic acid injection. World J Stem Cells 2026; In press
2026-02-11 | Browse: 8 | Download: 0
4
Zhang YZ, Wang YG. Mediator complex subunit 18: A novel breast cancer stem cell marker in tumor microenvironment. World J Stem Cells 2026; In press
2026-02-11 | Browse: 4 | Download: 0
5
Méndez-Toro A, Rojas-Ruiz IT, Silva-DiazGranados LE, Ruano-Cadena A, Paz-Meneses MA, Novoa-Alvarez RA. Prognostic impact of right ventricular dilatation and echocardiography use criteria in hospitalized COVID-19 patients. World J Methodol 2026; In press
2026-02-11 | Browse: 3 | Download: 0
6
Sholkamy A, El-Meligui A, Saad EH, Amin S, Makram M, Elmansy N, Mousa S. Association between overt, subclinical hypothyroidism and metabolic dysfunction-associated steatotic liver disease using magnetic resonance imaging. World J Hepatol 2026; In press
2026-02-11 | Browse: 3 | Download: 0
7
Giangregorio F, Civaschi E, Mazzocchi S, Romano D, Clini P, Centenara E, Casale U, Catucci D. Beyond fibrosis: The imperative for dual steatosis and fibrosis assessment in chronic hepatitis B and metabolic dysfunction-associated steatotic liver disease co-pathology. World J Hepatol 2026; In press
2026-02-11 | Browse: 4 | Download: 0
8
Dieninyte E, Pliuskute K, Jarasunas J, Stanaitis J, Poskus T. Endoscopic retrograde cholangiopancreatography associated perforations: 10-year experience of a large volume center. World J Gastrointest Endosc 2026; In press
2026-02-11 | Browse: 2 | Download: 0
9
Liu YM, Liu M, Yuan H, Li B. Double-edged role of N6-methyladenosine reader YTH structural domain family protein 2 in neurological disorders: Molecular mechanisms and translational prospects. World J Exp Med 2026; In press
2026-02-11 | Browse: 3 | Download: 0
10
Choudhary N, Zahid M, Ahmad M, Shaukat M, Tariq M, Rajeshwara S, Usman S, Wajid T, Awosika A. Neurobiological mechanisms linking vitamin d signaling to cognitive decline and neurodegeneration: Untangling epidemiology, pathophysiology, and evidence. World J Exp Med 2026; In press
2026-02-11 | Browse: 4 | Download: 0
11
Algharabeh MZ, Dreidi MM, Subuh NM, Almahmoud OH. Risk factors for bronchopulmonary dysplasia among preterm infants born before thirty-two weeks of gestation in Palestinian private hospitals. World J Clin Pediatr 2026; In press
2026-02-11 | Browse: 6 | Download: 0
12
Sun ZG, Wu WX, Chen SX, Zhang YJ, Jie JZ. Improved prognostic stratification of the revised ninth edition American Joint Committee on Cancer staging system for colorectal cancer. World J Gastroenterol 2026; In press
2026-02-11 | Browse: 7 | Download: 0
13
Zhang SH, Yang Y, Zhang Y. Breast cancer and metabolic comorbidities: From epidemiology and molecular mechanisms to precision interventions. World J Clin Oncol 2026; In press
2026-02-11 | Browse: 3 | Download: 0
14
Reddy R, Bhattacharya S. Glycated hemoglobin and risk stratification in gestational diabetes: An editorial perspective. World J Diabetes 2026; In press
2026-02-11 | Browse: 5 | Download: 0
15
Zhu CY, Fang ZR, Hua LY, Jin H, Xu XY, Liu XL, Zhang YM, Rao ZC. Serum 25-hydroxyvitamin D and peripheral thyroid hormone sensitivity in euthyroid type 2 diabetes: Linear estimates and low-range threshold. World J Diabetes 2026; In press
2026-02-11 | Browse: 4 | Download: 0
16
Chen CY, Hsu YH. Complete resolution of massive chronic subdural hematoma with refined layered middle meningeal artery embolization: A case report. World J Clin Cases 2026; In press
2026-02-11 | Browse: 3 | Download: 0
17
Zhang YW, Xu MR, Li MH, Li LX. Product of C-reactive protein and fasting C-peptide indicates cardiovascular risk in type 2 diabetes: A real-world study. World J Diabetes 2026; In press
2026-02-11 | Browse: 5 | Download: 0
18
Jaurretche SPA, Balañá C, Bascolo RM. Mineralocorticoid receptor genetics: A scoping review. World J Med Genet 2026; In press
2026-02-11 | Browse: 14 | Download: 0
19
Tsikopoulos I, Knight SL, Katsimperis S, Riley C, Helal M, Nobrega R. Acoustic wave device for prevention of recurrent suprapubic catheter blockage in neurogenic bladder. World J Clin Cases 2026; In press
2026-02-11 | Browse: 3 | Download: 0
20
Wang ZW, Jia L, Qu LK, Gong GH. Inhibiting exosomal miR-191 can induce ferroptosis in macrophages, thereby delaying the progression of colorectal cancer. World J Gastrointest Oncol 2026; In press
2026-02-11 | Browse: 4 | Download: 0
1034 items  Read more >>
Author Reviews
1
"The peer-review process of World Journal of Gastroenterology is highly professional, efficient and rigorous. The editorial team shows ..."  [Read more]
"The peer-review process of World Journal of Gastroenterology is highly professional, efficient and rigorous. The editorial team shows excellent efficiency in manuscript handling, with timely and clear communication during submission, review and revision. The invited reviewers are authoritative experts in gastroenterology, who provide objective, detailed and constructive comments that significantly improve the academic quality and logical rigor of the manuscript. The whole review procedure is transparent and well-organized, avoiding unnecessary delays and bringing a smooth experience to authors. We sincerely appreciate the dedicated work of the editorial office and reviewers, and highly recommend this journal to researchers in the field of gastroenterology. "  [Collapse]
Xu S, Zhu Z, Zhang HM, Xu YT, Shi PH, Zheng Y, Chen YT, Lu GR, Zheng BJ. Targeting Dialister-driven succinate accumulation: A novel strategy for Crohn’s disease activity control and recurrence prevention. World J Gastroenterol 2026; 32(8): 116173
2
"The editors and reviewers offered insightful and constructive feedback throughout the entire submission process, which significantly ..."  [Read more]
"The editors and reviewers offered insightful and constructive feedback throughout the entire submission process, which significantly improved the clarity and rigor of the manuscript. Their thorough evaluations and detailed suggestions not only enhanced the overall quality of the work but also demonstrated their exceptional expertise and dedication. We are truly grateful for their time, effort, and professional guidance. "  [Collapse]
Li WJ, Li LZ. Artificial intelligence in mobile health applications: A comprehensive review of its role in diabetes care. World J Methodol 2026; 16(1): 107488
3
"The manuscript submission system is user-friendly. Each step is clearly described. The files, including images, are easy to upload. ..."  [Read more]
"The manuscript submission system is user-friendly. Each step is clearly described. The files, including images, are easy to upload. The peer review process is quick and hence the authors get a decision without delay. The review process is very smooth. Overall, the journal executes the entire process well. Thank you for the opportunity to write this feedback. "  [Collapse]
Dutta AK, Rao NV, Bharadwaj PK, Benny S. Frequency and characteristics of synchronous gastric cancers: Need for improved awareness and better detection. World J Gastrointest Oncol 2026; 18(2): 113508
4
"The entire editorial and production team managed our manuscript with notable efficiency and professionalism. We especially appreciate ..."  [Read more]
"The entire editorial and production team managed our manuscript with notable efficiency and professionalism. We especially appreciate the constructive and insightful feedback provided by the reviewers, which greatly enhanced the quality of our paper. Communication at every stage was clear and timely, and the editors proved to be highly accessible and supportive via email. We are very satisfied with the remarkably smooth and well-organized publication experience. "  [Collapse]
Zhu KY, Wang SJ, Li J, Ma PP, Feng SS, Guo L, Lu YB, Dong L, Ding DF. Association of serum bile acid profiles with the risk of gastrointestinal autonomic neuropathy in patients with type 2 diabetes mellitus. World J Diabetes 2026; 17(2): 112859
5
"Thank you to the editors of the magazine for their hard work, and it is your recognition that makes this article a success. Thanks ..."  [Read more]
"Thank you to the editors of the magazine for their hard work, and it is your recognition that makes this article a success. Thanks to the reviewers' comments, they gave us a lot of pertinent revisions and provided good guidance for our paper revisions. Thank you to all members of our research team for their cooperation and joint efforts. In addition, We appreciate the great help/technical support/experimental support from the Medical Research Center, Academy of Chinese Medical Sciences, Zhejiang Chinese Medical University. "  [Collapse]
Huang NF, Ling P, Xu YJ, Feng XF, Zheng Y, Sun T. Xing-Pi-Qing-Gan decoction alleviates alcoholic liver disease by down-regulating DDIT3 and restoring Nrf2/HO-1 antioxidant signaling: Multi-omics and experimental evidence. World J Gastroenterol 2026; 32(8): 115077
6
"I would like to thank you for allowing me to write a letter about your paper. I am pleased to have been able to write this paper ..."  [Read more]
"I would like to thank you for allowing me to write a letter about your paper. I am pleased to have been able to write this paper because I was able to point out that although orthopedic surgery, including devices, has advanced, in order for this technology to successfully lead to an improvement in quality of life, it is necessary to take into consideration the psychological aspects of patients undergoing surgery. "  [Collapse]
Nagamine T. Considering mental function for successful total knee arthroplasty in older people. World J Methodol 2026; 16(1): 107921
7
"Iam indebted to the journal for their fair peerreview process, which improved the quality of my article. The editorial team was of ..."  [Read more]
"Iam indebted to the journal for their fair peerreview process, which improved the quality of my article. The editorial team was of great help and always approachable through email. I sincerely thank the whole editorial team for their cooperation; it was great to be associated with you all. Looking forward to other such associations in the future. "  [Collapse]
Pathania J, Pathania V. Real-world effectiveness and safety of teduglutide in patients with short bowel syndrome. World J Gastrointest Pharmacol Ther 2026; 17(1): 117071
8
"Everything has gone smoothly, except for the publication timeline. Overall, I’m extremely happy with the process. The final article ..."  [Read more]
"Everything has gone smoothly, except for the publication timeline. Overall, I’m extremely happy with the process. The final article PDF looks excellent, and the supplementary / accessory details are well done. The quality of the work and presentation is truly satisfying. No other issues noted by me or other authors who were involved in making this manuscript. "  [Collapse]
Kalluru PKR, Valisekka SS, Katamreddy Y, Cherukuri A, Kuchi D, Siddenthi SM, Mandyam S. Addressing barriers and advancing equitable colorectal cancer screening in the lesbian, gay, bisexual, transgender, and queer/questioning population. World J Methodol 2026; 16(1): 109316
9
"It was a great experience to publish this manuscript in a well-established journal in the field of cardiology. The time to the decision ..."  [Read more]
"It was a great experience to publish this manuscript in a well-established journal in the field of cardiology. The time to the decision is amazing, aligning with the relevant reviewers' comments and a smooth revision process. Communication with the help desk and the editorial team was very good. Moreover, the proofreading and final production were of a high standard. "  [Collapse]
Elmenyar E, Abbara MA, Al-Ghoul Z, Al Mahmeed W, Cander B, Abdelrahman AS, Al-Thani H, El-Menyar A. Phenomenon of “de Winter” pattern, sign, or syndrome: A systematic scoping review and data analysis. World J Cardiol 2026; 18(2): 114561
10
"The peer-review process was conducted objectively and efficiently, with constructive comments that helped improve the quality of the ..."  [Read more]
"The peer-review process was conducted objectively and efficiently, with constructive comments that helped improve the quality of the manuscript. Editorial communication was clear and timely, and responses to queries were prompt. The editing and production services were professional, well organized, and completed within a reasonable timeframe, contributing to a smooth publication process. "  [Collapse]
Bouayad A. Human leukocyte antigen variants and clinical features of primary biliary cholangitis: Cumulative contributions. World J Clin Cases 2026; 14(5): 115814
11
"The peer review process was thorough, rigorous, and highly constructive. The reviewers provided insightful and well-substantiated ..."  [Read more]
"The peer review process was thorough, rigorous, and highly constructive. The reviewers provided insightful and well-substantiated comments that helped refine the methodology, improve clarity, and strengthen the scientific message of the manuscript. Their feedback encouraged critical reflection and led to meaningful revisions that enhanced the overall quality and robustness of the study. This process exemplifies the value of transparent and objective peer review in advancing reliable and impactful scientific research. "  [Collapse]
Karavidas N, Tzatzaliaris D. Tele-scoliosis-screening and treat protocol: A hybrid in-person and online approach for scoliosis treatment in remote patients. World J Methodol 2026; 16(1): 107307
12
"The publication process was exceptionally smooth and efficient from initial submission through final publication. The peer-review ..."  [Read more]
"The publication process was exceptionally smooth and efficient from initial submission through final publication. The peer-review stage was handled in a timely manner, with clear communication and constructive feedback that helped improve the manuscript without unnecessary delays. Editorial decisions were prompt, and the overall workflow felt well organized and transparent. After acceptance, the production phase was equally fast, including copyediting, proof preparation, and final online release. Overall, the journal demonstrated a professional, responsive, and streamlined process with a genuinely speedy transition from review to production. "  [Collapse]
Karmakar R, Kandalkar A, Mukundan A. Total neoadjuvant therapy in rectal cancer: Challenging traditions without compromising surgical safety. World J Gastrointest Oncol 2026; 18(2): 115507
13
"I would like to express my sincere gratitude to the entire editorial and production team for the outstanding support throughout the ..."  [Read more]
"I would like to express my sincere gratitude to the entire editorial and production team for the outstanding support throughout the publication process. From submission to final online release, the experience was smooth, professional, and remarkably well coordinated. Communication from the editorial office was clear, timely, and always courteous, which made each stage of revision and production straightforward and efficient. I was particularly impressed by the quality and constructiveness of the peer-review process. The reviewers’ comments were thoughtful, relevant, and clearly aimed at strengthening the scientific rigor and clarity of the manuscript. Their feedback helped refine both the structure and presentation of the work, ultimately improving the overall quality of the final publication. It is evident that the journal maintains a high standard in selecting knowledgeable and engaged reviewers. The editorial guidance provided during revisions was also excellent. Instructions were precise and practical, allowing us to address all requirements without confusion or unnecessary delays. The production stage was equally efficient, with careful attention to formatting, language quality, and presentation. The final published version reflects a high level of editorial care and professionalism. Overall, this has been a very positive and rewarding publishing experience. I deeply appreciate the dedication of everyone involved — from assistant editors and reviewers to language editors and production staff — whose collective efforts ensure the high quality and integrity of the journal. I look forward to future collaborations and would gladly recommend this journal to colleagues seeking a reliable, rigorous, and author-supportive publication venue. "  [Collapse]
Prodan R, Soldera J. Mirtazapine for the treatment of irritable bowel syndrome: A systematic review. World J Methodol 2026; 16(1): 107908
14
"I would like to express my sincere gratitude to the entire editorial and production team for the outstanding support throughout the ..."  [Read more]
"I would like to express my sincere gratitude to the entire editorial and production team for the outstanding support throughout the publication process. From submission to final online release, the experience was smooth, professional, and remarkably well coordinated. Communication from the editorial office was clear, timely, and always courteous, which made each stage of revision and production straightforward and efficient. I was particularly impressed by the quality and constructiveness of the peer-review process. The reviewers’ comments were thoughtful, relevant, and clearly aimed at strengthening the scientific rigor and clarity of the manuscript. Their feedback helped refine both the structure and presentation of the work, ultimately improving the overall quality of the final publication. It is evident that the journal maintains a high standard in selecting knowledgeable and engaged reviewers. The editorial guidance provided during revisions was also excellent. Instructions were precise and practical, allowing us to address all requirements without confusion or unnecessary delays. The production stage was equally efficient, with careful attention to formatting, language quality, and presentation. The final published version reflects a high level of editorial care and professionalism. Overall, this has been a very positive and rewarding publishing experience. I deeply appreciate the dedication of everyone involved — from assistant editors and reviewers to language editors and production staff — whose collective efforts ensure the high quality and integrity of the journal. I look forward to future collaborations and would gladly recommend this journal to colleagues seeking a reliable, rigorous, and author-supportive publication venue. "  [Collapse]
Shah Q, Soldera J. Exploring effectiveness of Metronidazole, Bismuth, and Rifaximin in treating small intestinal bacterial overgrowth and irritable bowel syndrome: A systematic review. World J Methodol 2026; 16(1): 107169
15
"Everything was excellent. The editorial office services and prompt response to requests were enthusiastic. Also, the peer review ..."  [Read more]
"Everything was excellent. The editorial office services and prompt response to requests were enthusiastic. Also, the peer review process could be characterized by great satisfaction. Thank you very much for your cooperation. I am looking forward to continuing this scientific activity. I hope to continue with the best impressions. Best regards from Thessaloniki, Greece. "  [Collapse]
Marneri AG, Pavlidis ET, Stavrati KE, Mouratidou C, Kotoulas SC, Ballas KD, Pavlidis TE. Effects of rosuvastatin treatment and other statins on burn wound healing. World J Methodol 2026; 16(1): 112686
16
"Very good quality of peer review. The process was very easy and with a lot of efforts from all the parts. The only thing I would like ..."  [Read more]
"Very good quality of peer review. The process was very easy and with a lot of efforts from all the parts. The only thing I would like to suggest is a modification: for the first time submitting the paper, the website could be set just as the same as the pattern of when the paper was accepted with the tables and main topics already in order and you just set the data inside the tables. "  [Collapse]
Nunes BCM, Rocha RSP, Berzin TM, Franco MC, Kum AST. Staged multimodal endoscopic vacuum therapy for a complex gastro-pleuro-broncho-cutaneous fistula: A case report. World J Clin Cases 2026; 14(5): 117850
17
"The journal’s review process was thorough, constructive, and highly professional, providing clear and insightful feedback that ..."  [Read more]
"The journal’s review process was thorough, constructive, and highly professional, providing clear and insightful feedback that significantly improved the quality of the manuscript. The timely communication and balanced, expert evaluation reflected a strong commitment to academic rigor and author support. We thank the editors for the chanche to publish in this esteemed journal. "  [Collapse]
Deligiannis P, Katsimperis S, Kyriazis I, Angelopoulos P, Neofytou P, Kapsalos-Dedes SG, Triantafyllou P, Arseniou P, Katelani S, Papatsoris A. Fluoroscopy-guided transurethral resection with antegrade guidewire assistance for retrieval of a buried double-J stent: A case report. World J Clin Cases 2026; 14(5): 117384
18
"We would like to express our sincere gratitude to the editorial team and the reviewers for their exceptional support. Working on this ..."  [Read more]
"We would like to express our sincere gratitude to the editorial team and the reviewers for their exceptional support. Working on this manuscript has been a genuine pleasure. We are deeply appreciative of the board's invaluable assistance, which included meticulous feedback and constructive suggestions at every stage—from initial submission to final revisions—in preparing the manuscript for publication. "  [Collapse]
Pereverzeva KG, Glenza A, Yakushin SS. Oral anticoagulant therapy and outcomes in new-onset atrial fibrillation during acute myocardial infarction: A systematic review and meta-analysis. World J Cardiol 2026; 18(2): 114265
19
"WJGO is a very good magazine. It actively seeks peer-reviewers and has clear requirements for the manuscripts. All the editors are ..."  [Read more]
"WJGO is a very good magazine. It actively seeks peer-reviewers and has clear requirements for the manuscripts. All the editors are very friendly and work highly efficiently. The editors and I had a series of discussions about the details in the manuscript. I will continue to submit my articles to WJGO in the future. "  [Collapse]
Zhang Y, Li ZX, Ma DY, Liu F. Solitary esophageal metastasis ten years after curative resection of stage I rectal adenocarcinoma: A case report. World J Gastrointest Oncol 2026; 18(2): 113494
20
"Enjoyed the peer review process, which was efficient and effective. I think the submission system is user friendly, allow for rapid ..."  [Read more]
"Enjoyed the peer review process, which was efficient and effective. I think the submission system is user friendly, allow for rapid communication between the journal and authors. Additionally enjoyed the clear and concise peer review report. Would do this all over again, if given another chance. Congratulations to the F6 publishing systems. Keep up the good work. Kevan English, MD Internal Medicine University of Nebraska Medical Center "  [Collapse]
Garcia R, English K. Mixed hepatocellular-cholestatic liver injury from cefepime: A case report. World J Clin Cases 2026; 14(4): 117573
20715 items  Read more >>
Article Quality Tracking-Peer-Review
1
"Peroxiredoxin 1 (Prdx1) has recently been shown to effectively inhibit the growth of colon cancer in experimental carcinogenesis in ..."  [Read more]
"Peroxiredoxin 1 (Prdx1) has recently been shown to effectively inhibit the growth of colon cancer in experimental carcinogenesis in mice. The anticancer activity of this substance is based on pyroptosis. Pyroptosis is a key component of cell death. It directly suppresses the tumor by promoting gasdermin D-induced cell lysis and by releasing inflammatory factors that affect the so-called “cell death-anti-tumor immunity”. Peroxiredoxin 1 warrants further investigation for the development of co-expression markers (Prdx1/GSDMD). Furthermore, as the authors note, the efficacy of combination therapies targeting rPrdx1 should be studied promptly to promote personalized treatment of colon cancer."  [Collapse]
Chen ZK, Zhao JW, Meng WY, Wang YG. Peroxiredoxin 1 as a novel pyroptosis inducer in colorectal cancer: Insights and future directions. World J Gastroenterol 2026; 32(8): 116016
2
"As a systematic review, this paper comprehensively covers the core research content of tumor organoids and provides a systematic ..."  [Read more]
"As a systematic review, this paper comprehensively covers the core research content of tumor organoids and provides a systematic collation of knowledge in the field. However, there is room for optimization in terms of data rigor, content depth, and clinical relevance. To enhance its academic value, it is advisable to supplement detailed information on literature screening, strengthen the connection between technical details and clinical applications, enrich the comprehensiveness of discussions on limitations, and optimize the timeliness of case data and references. Other comments: Figures and tables: I think the paper should have more figures, rather than only tabels."  [Collapse]
Agrawal H, Tanwar H, Gupta N. Tumor organoids in translational cancer research: Models for personalized therapy. World J Transl Med 2026; 12(1): 113050
3
"The manuscript is written well. Its structure is appropriate for this type of article. Ethical approval form meets the requirements. ..."  [Read more]
"The manuscript is written well. Its structure is appropriate for this type of article. Ethical approval form meets the requirements. Methods are appropriate and effective. Results are appropriate of methods and are authentic. Tables and biostatistics data are perfect. The references are adequate of topic. Language of article is satisfied."  [Collapse]
Alvarez M, Luna M, Suarez E, Rincon O, Guzman I, Mancera P. Thyroid collision tumor and Graves’ disease: A case report and review of literature. World J Clin Cases 2026; 14(5): 117016
4
"The manuscript is written well. Its structure is appropriate for this type of article. Ethical approval form meets the requirements. ..."  [Read more]
"The manuscript is written well. Its structure is appropriate for this type of article. Ethical approval form meets the requirements. Methods are appropriate and effective. Results are appropriate of methods and are authentic. Tables and biostatistics data are perfect. The references are adequate of topic. Language of article is satisfied."  [Collapse]
Bouayad A. Human leukocyte antigen variants and clinical features of primary biliary cholangitis: Cumulative contributions. World J Clin Cases 2026; 14(5): 115814
5
" Importantly, the authors of this study identified that prolonged disease duration and anxiety are independent high-risk factors ..."  [Read more]
" Importantly, the authors of this study identified that prolonged disease duration and anxiety are independent high-risk factors for refractory GERD. Anti-anxiety interventions, standardized exercise prescriptions, and lifestyle factors such as sleep and weight management should be explored as a multidimensional risk-targeted intervention. However, in the real world, we have to distinguish between true refractory GERD and refractory reflux-like symptoms. A systematic evaluation of the patients is essential, as up to 40% of patients with GERD report inadequate symptom control with PPIs, but only a minority have true refractory GERD. Therefore, we should evaluate multiple aspects of the patient's behavior (e.g., optimizing PPI therapy, ensuring correct timing, increasing to twice-daily dosing, or switching to a different PPI) before proceeding with exercise prescriptions and anti-anxiety interventions. Moreover, alternative pharmacologic options, including Histamine-2 receptor antagonists (administered at bedtime for nocturnal symptoms, though tachyphylaxis limits long-term efficacy), potassium-competitive acid blockers, alginates and antacids, prokinetic agents, neuromodulators, bile acid sequestrants, and lifestyle modifications, should be tried in these patients, indicating that individualized, multidisciplinary care is essential. "  [Collapse]
Zuo XY, Chen QQ. Beyond monotherapy by acid suppression: Reshaping the management of refractory gastroesophageal reflux disease. World J Gastroenterol 2026; 32(7): 116425
6
"The paper is interesting and fits well with the body of work addressing nontraditional factors causing myocardial infarction. In ..."  [Read more]
"The paper is interesting and fits well with the body of work addressing nontraditional factors causing myocardial infarction. In particular the discussion is well written. I don't know if I've missed it, but I haven't seen a correlation between myocardial infarction and ethnicity. In Europe ethnicity is an important factor, given that Asian populations have a higher incidence of myocardial infarction at young ages."  [Collapse]
Patel T, Farhan M, Bhatt NK, Fatah HA, Peniel JJ, Kaulgud VV, Mathew T, Bapat AM, Harazeen WS, Alatta AN, Awosika A. Non-traditional risk factors for myocardial infarction in adults under forty: A systematic review of emerging trends. World J Cardiol 2026; 18(2): 116172
7
" The manuscript is written well. Its structure is appropriate for this type of article. Ethical approval form meets the requirements. ..."  [Read more]
" The manuscript is written well. Its structure is appropriate for this type of article. Ethical approval form meets the requirements. Methods are appropriate and effective. Results are appropriate of methods and are authentic. Tables and biostatistics data are perfect. The references are adequate of topic. Language of article is satisfied."  [Collapse]
Lee H, Han YH, Chung JW, Kim KO, Kwon KA, Kim JH. Upper gastrointestinal bleeding with duodenal varix: A case report. World J Clin Cases 2026; 14(4): 116648
8
"Obese people are prone to GERD and SG increases the frequency of GERD after surgery, so SG is worth considering for those with GERD. ..."  [Read more]
"Obese people are prone to GERD and SG increases the frequency of GERD after surgery, so SG is worth considering for those with GERD. RYDG and OAB are good weight loss surgeries without the risk of GERD. For patients with GERD, the surgical procedure should be selected as suggested by authors."  [Collapse]
Xing Y, Yan WM, Bai RX. Effects of bariatric surgery on obesity associated gastroesophageal reflux disease: Insights from a systematic review and network meta-analysis. World J Gastroenterol 2026; 32(6): 114600
9
"Obesity is associated with a high proportion of patients with gastroesophageal reflux disease (GERD). In recent years, metabolic and ..."  [Read more]
"Obesity is associated with a high proportion of patients with gastroesophageal reflux disease (GERD). In recent years, metabolic and bariatric surgery (MBS) has been considered the most effective treatment for weight loss in obese patients. The most commonly performed surgical procedures are sleeve gastrectomy (SG), Roux-en-Y gastric bypass (RYGB), and single-anastomotic gastric bypass (OAGB). MBS has different effects on obesity-related GERD depending on the type of procedure performed. The results suggest that RYGB consistently leads to significant improvement or remission of GERD symptoms, reduced HCl exposure, and reduced need for PPI therapy in obese patients. RYGB and OAGB are more effective than SG for weight loss and GERD control. RYGB is therefore the preferred bariatric procedure for obese patients with clinically evident GERD. SG is associated with a higher risk of new onset or worsening of GERD, an increased incidence of erosive esophagitis, and an increased risk of Barrett's esophagus. The pathophysiology of these effects is multifactorial and involves changes in gastric anatomy and lower esophageal sphincter function. Therefore, the choice of the type of surgical procedure that should be performed must be individualized, with RYGB being preferred in obese patients with significant GERD or Barrett's esophagus, while SG can be performed in patients without reflux symptoms but requires careful preoperative assessment of GERD risk. The aforementioned data should be taken seriously and guide the physician and patient with obesity and GERD towards making the right surgical decisions."  [Collapse]
Xing Y, Yan WM, Bai RX. Effects of bariatric surgery on obesity associated gastroesophageal reflux disease: Insights from a systematic review and network meta-analysis. World J Gastroenterol 2026; 32(6): 114600
10
"Fatigue is a frequent and particularly burdensome symptom with significant impact on the quality of life of patients with Crohn's ..."  [Read more]
"Fatigue is a frequent and particularly burdensome symptom with significant impact on the quality of life of patients with Crohn's disease. In daily medical practice, its treatment is often inadequate since it is usually attributed to side effects of the drugs administered to treat the underlying disease or to psychological causes. The study under review found that indeed, psychological symptoms such as depression, anxiety, stress of any cause, and insomnia are related to its occurrence. In particular, stress is likely to induce the symptom through probable immunological effects. Of interest was the frequent occurrence of fatigue with increased white blood cell count. It therefore seems that fatigue in patients with Crohn's disease has a multifactorial etiology, not exclusively attributable to disease activity or inflammatory markers. As the researchers pointed out, fatigue among IBD patients should receive greater attention in the near future. By conducting additional relevant studies, we will be able to accurately identify the factors that contribute to fatigue, enabling us to develop and implement strategies to effectively identify and support patients experiencing fatigue."  [Collapse]
Morais TC, Couto G, Silva BCD, Lisbôa RA, da Cruz BS, Viana MGF, de Sousa GBC, Arenas LP, Nery ES, Fortes FML, de Almeida NP, Pimentel AM, Fontes JAM, Surlo VC, Chebli JF, Rocha R, Santana GO. Psychological and hematological factors associated with fatigue in patients with Crohn’s disease receiving pharmacological treatment. World J Gastroenterol 2026; 32(5): 115673
11
"The editorial article summarizes current knowledge and clinical approaches to the diagnosis and management of cancer-related incomplete ..."  [Read more]
"The editorial article summarizes current knowledge and clinical approaches to the diagnosis and management of cancer-related incomplete intestinal obstruction (CRIO). Given the multifactorial and complex pathophysiology of CRIO, it is inherently challenging to comprehensively describe all clinical conditions. Nevertheless, the authors successfully present a well-structured and comprehensive overview by organizing the discussion into a clear and logical framework."  [Collapse]
Liu JL, Wang CX, Wang HL. Advances in the management of cancer-related incomplete intestinal obstruction: Therapeutic strategies and emerging interventions. World J Gastroenterol 2026; 32(5): 115030
12
"This article provides an interesting topic, with valuable first-hand information. There were also some notable limitations, as ..."  [Read more]
"This article provides an interesting topic, with valuable first-hand information. There were also some notable limitations, as addressed in the following: Of the “Abstract”. The aim does not match well the conclusion. Some “Keywords” are not adequate. “Metagenomic next-generation sequencing” should be moved from “Keywords”. There was no “analysis” or associated description in the “Methods” of the “Abstract”, and this is not adequate. The “Results” in “Abstract” were not consistent with the “Methods” of the “Abstract”. There was no gold standard (guidelines) and criteria for the diagnosis of pulmonary nocardiosis in the “Materials and Methods”. The imaging characteristics (Table 4) were not complete, and which should include a complex item comprising two or more imaging characteristics of the lungs . A total of the pulmonary nocardiosis caused by different species in Table 4 was not 102. The pulmonary nocardiosis treated by different medications in Table 5 was not clear, some patients treated using more than one medications, and the total number was not 102. Figure 1 was not necessary, and associated information can be listed in table or presented in text. Images of pulmonary nocardiosis were not sufficient, and more other representative images had better be added. The English is not professionalism. The “Conclusion” that “Nocardia pneumonia commonly coexists with bronchiectasis. Although mNGS has greatly enhanced its detection rate, N. wallacei pneumonia is distinguished on chest CT by its primary presentation of bronchopneumonia, unlike other types.” was not adequate, and it was not well matching the contents of the “Results”."  [Collapse]
Wang HJ, Zhang YN, An L. Clinical and radiographic feature of pulmonary nocardiosis: A study of 102 cases. World J Radiol 2026; 18(1): 114552
13
"Please explain in more detail the mechanism of carcinogenesis caused by bile reflux into the esophagus. Author write Bile acids can ..."  [Read more]
"Please explain in more detail the mechanism of carcinogenesis caused by bile reflux into the esophagus. Author write Bile acids can act through specific signalling pathways, activating nuclear farnesoid X receptor and plasma-membrane-bound G protein-coupled bile acid receptors, and also likely through the interaction between these receptors. The coupling of G protein-coupled bile acid receptor to the stimulatory protein Gs leads to activation of adenylate cyclase, intracellular cAMP accumulation and protein kinase A activation, directly impacting on smooth muscle contractile activity. Also, the author's theory of how bile reflux reduces esophageal motility is a new and interesting one. I would like to see more detailed research into esophageal motility beyond the 24-hour pH meter. "  [Collapse]
Gadelha KKL, Santos AA, Correia-de-Sá P, Magalhães PJC, da Silva MTB. Can bile salts affect the contractile oesophageal activity associated with gastroesophageal reflux disease? World J Gastroenterol 2026; 32(4): 114560
14
"The article presents a coherent and well‑structured argument by explaining why indocyanine green (ICG) fluorescence has become an ..."  [Read more]
"The article presents a coherent and well‑structured argument by explaining why indocyanine green (ICG) fluorescence has become an essential tool in hepatocellular carcinoma surgery and supporting this with evidence from systematic reviews and clinical studies. It logically organizes the diverse applications of ICG—segmental mapping, detection of superficial lesions, thermal ablation guidance, and tumor‑biology assessment—showing how each technique addresses specific surgical limitations. The discussion consistently links fluorescence patterns to pathological features and clinical decision‑making, reinforcing the article’s central claim that ICG enhances precision, safety, and oncologic outcomes in minimally invasive liver surgery."  [Collapse]
Piccolo G, Barabino M, Benuzzi L, Formisano G, Bianchi PP. Clinical applications of indocyanine green fluorescence for the treatment of hepatocellular carcinoma. World J Gastrointest Oncol 2026; 18(1): 114339
15
"The article maintains clear logical flow by presenting a rare SMARCB1‑deficient pancreatic rhabdoid carcinoma case and linking the ..."  [Read more]
"The article maintains clear logical flow by presenting a rare SMARCB1‑deficient pancreatic rhabdoid carcinoma case and linking the unusual initial presentation—spontaneous splenic rupture—to the tumor’s aggressive biology. Its diagnostic reasoning is coherent, moving from clinical findings to imaging, pathology, and molecular profiling that distinctly separate the ductal adenocarcinoma and rhabdoid components. The discussion logically integrates existing literature to highlight the rarity, poor prognosis, and potential benefit of aggressive multimodal therapy, underscoring the need for targeted approaches in this molecular subtype."  [Collapse]
Yao WQ, Ma XY, Wang GH. Clinicopathologic features of SMARCB1/INI1-deficient pancreatic undifferentiated rhabdoid carcinoma: A case report and review of literature. World J Gastrointest Oncol 2026; 18(1): 114021
16
"The article demonstrates strong logical coherence by clearly establishing the clinical gap in evidence for treating esophageal cancer ..."  [Read more]
"The article demonstrates strong logical coherence by clearly establishing the clinical gap in evidence for treating esophageal cancer patients with liver metastases and justifying the need to compare chemotherapy alone with chemoimmunotherapy. Its methodology is rigorous and transparent, using well‑defined inclusion criteria, detailed baseline characteristics, and standardized outcome measures such as RECIST, overall survival, and progression‑free survival. The conclusions logically follow from the data, showing that adding immune checkpoint inhibitors significantly improves survival and response rates without increasing severe toxicity, and the study further strengthens its argument by identifying independent prognostic factors through multivariate Cox regression analysis."  [Collapse]
Dai EH, Que SH, Xu H, Zhong GQ, Zhang Z, Liang X, Zhai SW, Li YT, Wang JJ, Feng W. Efficacy and safety of immune checkpoint inhibitors plus chemotherapy in esophageal cancer patients with liver metastases. World J Gastrointest Oncol 2026; 18(1): 113440
17
"The study presents a logically coherent argument by clearly identifying the clinical gap in evidence for nivolumab‑based chemotherapy ..."  [Read more]
"The study presents a logically coherent argument by clearly identifying the clinical gap in evidence for nivolumab‑based chemotherapy in advanced gastric cancer with massive ascites and justifying the need for retrospective evaluation. Its methodology is well‑structured, using clearly defined ascites‑burden groups and standardized clinical criteria to ensure meaningful comparisons of outcomes and safety profiles. The conclusions follow naturally from the data, showing that although prognosis remains poor in the high‑ascites group, nivolumab plus chemotherapy provides measurable ascites improvement and acceptable toxicity, supporting its potential therapeutic value in this challenging population."  [Collapse]
Matsumoto T, Sugimoto S, Omori R, Makiyama C, Nakasya A, Nagai H, Yasui H, Higashi R, Sasamoto A, Satake H. Efficacy and safety of nivolumab plus chemotherapy in patients with advanced gastric cancer with massive ascites. World J Gastrointest Oncol 2026; 18(1): 112944
18
"The document presents a clear, logical structure with well‑labeled sections and concise summaries that guide the reader through the ..."  [Read more]
"The document presents a clear, logical structure with well‑labeled sections and concise summaries that guide the reader through the study’s objectives and findings. The methods and results are supported by detailed experimental design and high‑quality figures and tables, which enhance reproducibility and data transparency. The discussion highlights clinical relevance and practical implications, effectively linking mechanistic insights to potential therapeutic strategies."  [Collapse]
Vescio F, Curcio S, Aquila I, Ammendola M, Tarallo AP. Right patient approach to experimental stromal cell therapies for gastrointestinal tumors. World J Gastrointest Oncol 2026; 18(1): 112630
19
"Intraductal papillary mucinous neoplasms (IPMN) are clinically important precancerous conditions of the pancreas. Their accurate ..."  [Read more]
"Intraductal papillary mucinous neoplasms (IPMN) are clinically important precancerous conditions of the pancreas. Their accurate diagnosis requires a combination of imaging and endoscopic techniques. Pancreatoscopy enables direct visualization of the pancreatic duct, targeted biopsies, and the definition of disease boundaries. Existing data support the view that pancreatoscopy is a satisfactory and promising method for determining which patients with IPMN should undergo surgery, as well as the extent of resection for each patient. However, excessive enthusiasm should not prevail. The method is not widely applied; learning requires a dedicated endoscope and a sufficient number of patients per year to maintain and further increase experience, which is a very important factor. For the widespread acceptance and adoption of the method, it is necessary to conduct prospective, very well-designed multicenter studies aiming to precisely determine many parameters e.g. its diagnostic contribution and accuracy, which patients should undergo the examination, what is the impact on therapeutic decisions, what is the cost-benefit ratio and finally to determine whether it improves the survival and/or quality of life of patients. Based on the above observations, pancreatoscopy should be decided on a case-by-case basis and performed in specialized centers."  [Collapse]
Abusharar M, Barritt C, Mavroeidis VK, Aroori S. Role of pancreatoscopy in the management of suspected and confirmed intraductal papillary mucinous neoplasm of the pancreas. World J Gastroenterol 2026; 32(4): 112635
20
"The paper is highly informative and comprehensive. The authors have gathered and synthesized the most significant and relevant data ..."  [Read more]
"The paper is highly informative and comprehensive. The authors have gathered and synthesized the most significant and relevant data from the literature, presenting it in a clear and well-structured manner. The review provides valuable insights into the topic, highlights key mechanisms and clinical implications, and offers a solid foundation for future research and practical applications."  [Collapse]
Singh B, Singh H, Kaur S, Singh B. Preclinical pharmacology studies of zingerone with special reference to potential therapeutic applications. World J Immunol 2026; 16(1): 111511
15941 items  Read more >>
Peer-Reviewers and Manuscript Statistics
Editorial board members
2264
Peer-reviewers
36059
Manuscripts received today
0
Manuscript reviews today
0
Unhandled manuscripts today
174
Active peer-reviewers today
311
Reviewer acceptance today
3
Reviewer refusals today
2
Total accepted manuscripts
40185
Total rejected manuscripts
44616
Total peer-reviewers
4687615
Total submissions
38034
Baishideng Publishing Group (BPG) publishes 47 peer-reviewed, open-access journals covering a broad range of topics in clinical medicine, as well as several topics in biochemistry and molecular biology, relevant to human health today.
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Sign In
  • BPG Management System
  • F6Publishing-Submit a Manuscript
  • F6Publishing-世界华人消化杂志在线投稿
  • RCA Management System
English
  • English
  • 简体中文
BPG Journal List
Reference Citation Analysis
  • Find an Article (57725788)
  • Find an Article PDF (5980012)
  • Today's Articles (5818)
  • Find a Category (128)
  • Find a Journal (7876)
  • Find a Scholar (4478)
  • Find an Academic Assistant (52)
  • Subscribe (503)
BPG E-Books
BPG Blog
All Journal Articles
1

Lim Y, Lim WB, Bonner T, Wood L, Volpin A. Rethinking meniscal repair in patients over 40: Extending the boundaries of joint preservation. World J Methodol 2026; 16(1): 113664

2026-03-20 | Browse: 59 | Download: 22
2

Rath S. Advancing chronic low back pain management: Insights from amitriptyline and duloxetine comparison. World J Methodol 2026; 16(1): 113191

2026-03-20 | Browse: 61 | Download: 25
3

Marneri AG, Pavlidis ET, Stavrati KE, Mouratidou C, Kotoulas SC, Ballas KD, Pavlidis TE. Effects of rosuvastatin treatment and other statins on burn wound healing. World J Methodol 2026; 16(1): 112686

2026-03-20 | Browse: 65 | Download: 28
4

Nayak B, Mohapatra PR, Chakraborty K, Nanda J, Haripriya S, Mantha SP, Sethy M, Panda BB. Are iris masses in lung carcinoma always a metastasis: Two case reports. World J Methodol 2026; 16(1): 112458

2026-03-20 | Browse: 51 | Download: 22
5

Mandal D, Pulickal TV, Ahlawat D, Haqbeen W, Kashif I, Alamy H, Prattipati P, Jaladi P, Kabiaru P, Avula A, Kshetri S, Raza I, Shamieh S, Chhetri R. Sirolimus vs paclitaxel-coated balloons in in-stent coronary restenosis: A meta-analysis. World J Methodol 2026; 16(1): 111566

2026-03-20 | Browse: 78 | Download: 34
6

Aggarwal S, Morya AK, Kaur R, Gurnani B, Kaur K. Role of lifestyle modifications in glaucoma: A systematic review. World J Methodol 2026; 16(1): 110410

2026-03-20 | Browse: 58 | Download: 27
7

Ayyappan Unnithan AK. Update on hypoxic-ischemic brain injury: Prognosis and management. World J Methodol 2026; 16(1): 110342

2026-03-20 | Browse: 130 | Download: 45
8

Tariq Z, Faisal A, Basit A, Iftikhar A, Basil AM. Diagnostic dilemmas in hepatoid adenocarcinoma of the stomach: Navigating clinical and pathological loopholes. World J Methodol 2026; 16(1): 110272

2026-03-20 | Browse: 61 | Download: 30
9

Khan SMI, Waqas M, Khawar M, Batool A, Komel A, Ashraf MA, Saifullah M, Rana I. Temporal trends and disparities in substance use and diabetes mellitus-related mortality in the United States (1999–2022). World J Methodol 2026; 16(1): 110159

2026-03-20 | Browse: 70 | Download: 40
10

Jeyaraman M, Jeyaraman N, Nallakumarasamy A, Murugan S, Muthu S. Innovative prospects in 3D printed bio-scaffolds for osteochondral tissue engineering: A systematic review. World J Methodol 2026; 16(1): 109784

2026-03-20 | Browse: 71 | Download: 36
11

Patel N, Patel V, Murugan Y, Patel K, Varma V, Surani S. Integrating serum ferritin and neutrophil-to-lymphocyte ratio with Sequential Organ Failure Assessment score improves mortality prediction in sepsis. World J Methodol 2026; 16(1): 109733

2026-03-20 | Browse: 112 | Download: 51
12

Okasha HH, Alyouzbaki AZ, Tehami N, Abdellatef A. Fatty pancreas: Current insights and future perspectives. World J Methodol 2026; 16(1): 109580

2026-03-20 | Browse: 56 | Download: 29
13

Nag DS, Prasad S, Sahu S, Laik JK, Swain A, Anand R, Saroha S, Mahanty PR, Kumar H, Mistari W. Nottingham Hip Fracture Score and Acute Physiology and Chronic Health Evaluation-II: Predicting 30-day mortality in elderly hip fracture. World J Methodol 2026; 16(1): 109473

2026-03-20 | Browse: 90 | Download: 50
14

Kalluru PKR, Valisekka SS, Katamreddy Y, Cherukuri A, Kuchi D, Siddenthi SM, Mandyam S. Addressing barriers and advancing equitable colorectal cancer screening in the lesbian, gay, bisexual, transgender, and queer/questioning population. World J Methodol 2026; 16(1): 109316

2026-03-20 | Browse: 63 | Download: 23
15

Karaaytu E, Özdemir Ö. Vitamin D and allergic rhinitis: A mini-review. World J Methodol 2026; 16(1): 109252

2026-03-20 | Browse: 63 | Download: 35
16

Qiao C, Zhao XH, Jiao YC, Li HW, Guo N, Wei LY, Wang ZR, Li GL, Li DH. Tai Chi for treating cancer-related fatigue: A meta-analysis of randomized controlled trials. World J Methodol 2026; 16(1): 109145

2026-03-20 | Browse: 82 | Download: 39
17

Mundhra SK, Kochhar R. Methodological insights into fecal microbiota transplantation: Dissecting key approaches for success. World J Methodol 2026; 16(1): 108875

2026-03-20 | Browse: 74 | Download: 31
18

Mishra A, Juneja D. Decolonizing the gut from multidrug-resistant bacteria: Current strategies and future perspectives. World J Methodol 2026; 16(1): 108646

2026-03-20 | Browse: 62 | Download: 26
19

Senapati SG, Kothawala A, Ahluwalia V, Desai R. High Red Cell Distribution Width (RDW) as a Prognostic Indicator in Heart Failure. World J Methodol 2026; 16(1): 108611

2026-03-20 | Browse: 61 | Download: 21
20

Aher NB, Thothala Prabhakar PK, Thirukonda Govarthanam SK, Krishnamoorthy S. Adolescent varicocele, a Gordian knot: A comprehensive review of clinical perspectives and future directions. World J Methodol 2026; 16(1): 108384

2026-03-20 | Browse: 81 | Download: 32
62211 items  Read more >>
Featured Articles
1

Kim YK, Jung HI, Kim H, Bae SH. Ischemic duodenal injury due to systemic lupus erythematosus: A case report. World J Gastroenterol 2026; 32(8): 115654

2026-02-11 | Browse: 8 | Download: 38
2

Huang NF, Ling P, Xu YJ, Feng XF, Zheng Y, Sun T. Xing-Pi-Qing-Gan decoction alleviates alcoholic liver disease by down-regulating DDIT3 and restoring Nrf2/HO-1 antioxidant signaling: Multi-omics and experimental evidence. World J Gastroenterol 2026; 32(8): 115077

2026-02-11 | Browse: 4 | Download: 33
3

Yang M, Zhang CY. Molecular mechanisms of tumor-associated macrophages in hepatocellular carcinoma development and therapy. World J Gastroenterol 2026; 32(8): 115675

2026-02-11 | Browse: 6 | Download: 28
4

Isakov V, Goncharov A. Dual cut-offs and beyond: Expanding the role of transient elastography in primary biliary cholangitis. World J Gastroenterol 2026; 32(8): 115416

2026-02-11 | Browse: 4 | Download: 12
5

Yang YH. Bridging innovation and clinical reality: Interpreting the comparative study of deep learning models for multi-class upper gastrointestinal disease segmentation. World J Gastroenterol 2026; 32(8): 115297

2026-02-11 | Browse: 4 | Download: 12
6

Pati BK, Panda PK. Body size and infection: An immunological balancing act. World J Immunol 2026; 16(2): 114815

2026-02-11 | Browse: 1 | Download: 11
7

Huang SY, Lin WG, Lan H, Xu ZG, Zheng XX, Liu XB, Cheng YM, Li ZF, Ke MH. Mechanism of Xiaozhiling injection in the treatment of internal hemorrhoids based on changes in perianal blood flow and rectal submucosal fibers. World J Gastrointest Pharmacol Ther 2026; 17(1): 113444

2026-02-11 | Browse: 3 | Download: 28
8

Stasinos I, Voulgaris T, Kouimtsidis IA, Zantza SA, Leventaki FA, Theodosopoulos TA, Vlachogiannakos J, Apostolopoulos PA, Karamanolis GP. Impact of Endocuff addition to real-time computer-aided detection of colorectal neoplasia in a randomised tandem colonoscopy trial. World J Gastrointest Pharmacol Ther 2026; 17(1): 112825

2026-02-11 | Browse: 3 | Download: 32
9

Tomasic V, Ćaćić P, Siranovic Pongrac I, Pelajić S, Barsic N, Arefijev A, Lerotic I, Blazevic A, Bišćanin A. Impact of sedation on adenoma and polyp detection rates and cecal intubation in elderly patients undergoing screening colonoscopy. World J Gastrointest Pharmacol Ther 2026; 17(1): 112803

2026-02-11 | Browse: 3 | Download: 30
10

Kalra S, Goyal MK, Goyal K, Singh R, Vuthaluru AR, Goyal O. Unlocking the colon clock: Bridging the gap in colonic transit time studies for optimal management of chronic constipation. World J Gastrointest Pharmacol Ther 2026; 17(1): 111615

2026-02-11 | Browse: 3 | Download: 22
11

Bilotta AJ, Trebilcock JA, Hebda NJ, Sasan CK, Cooper KM, Rupawala AH. Artificial intelligence in the management of inflammatory bowel disease: What’s next? World J Gastrointest Pharmacol Ther 2026; 17(1): 112640

2026-02-11 | Browse: 3 | Download: 20
12

Agrawal H, Tanwar H, Gupta N. Tumor organoids in translational cancer research: Models for personalized therapy. World J Transl Med 2026; 12(1): 113050

2026-02-11 | Browse: 3 | Download: 17
13

Rath S. Advancing chronic low back pain management: Insights from amitriptyline and duloxetine comparison. World J Methodol 2026; 16(1): 113191

2026-02-10 | Browse: 7 | Download: 45
14

Mandal D, Pulickal TV, Ahlawat D, Haqbeen W, Kashif I, Alamy H, Prattipati P, Jaladi P, Kabiaru P, Avula A, Kshetri S, Raza I, Shamieh S, Chhetri R. Sirolimus vs paclitaxel-coated balloons in in-stent coronary restenosis: A meta-analysis. World J Methodol 2026; 16(1): 111566

2026-02-10 | Browse: 7 | Download: 61
15

Karavidas N, Tzatzaliaris D. Tele-scoliosis-screening and treat protocol: A hybrid in-person and online approach for scoliosis treatment in remote patients. World J Methodol 2026; 16(1): 107307

2026-02-10 | Browse: 5 | Download: 59
16

Aher NB, Thothala Prabhakar PK, Thirukonda Govarthanam SK, Krishnamoorthy S. Adolescent varicocele, a Gordian knot: A comprehensive review of clinical perspectives and future directions. World J Methodol 2026; 16(1): 108384

2026-02-10 | Browse: 6 | Download: 47
17

Okasha HH, Alyouzbaki AZ, Tehami N, Abdellatef A. Fatty pancreas: Current insights and future perspectives. World J Methodol 2026; 16(1): 109580

2026-02-10 | Browse: 5 | Download: 46
18

Katongole J, Akankwasa P, Namutosi E, Hakizimana T, Suleiman IA, Kakooza J, Lewis CR, Okurut E. Double incontinence among women globally: A systematic review and meta-analysis. World J Clin Urol 2026; 15(1): 115330

2026-02-10 | Browse: 4 | Download: 22
19

Elahi T, Ahmed S, Mubarak M. Urological footprint of chronic kidney disease: A nephrologist perspective on early detection and collaborative management. World J Clin Urol 2026; 15(1): 114707

2026-02-10 | Browse: 3 | Download: 16
20

Khalid A, Obadele OG, Alabi TO, Nedjim SA, Abdulwahab-Ahmed A, Mungadi IA. Practical approach to the review of bladder diverticulum and its management. World J Clin Urol 2026; 15(1): 114046

2026-02-10 | Browse: 3 | Download: 18
10449 items  Read more >>
Keyword Search Published Articles Processes
1
Case report
4755
2
Hepatocellular carcinoma
1758
3
Gastric cancer
1282
4
Colorectal cancer
1263
5
Prognosis
1092
6
Inflammatory bowel disease
861
7
COVID-19
843
8
Treatment
777
9
Diagnosis
759
10
Liver transplantation
745
11
Ulcerative colitis
691
12
Meta-analysis
672
13
Crohn’s disease
627
14
Endoscopy
622
15
Cirrhosis
613
16
Inflammation
602
17
Helicobacter pylori
595
18
Magnetic resonance imaging
587
19
Surgery
562
20
Pancreatic cancer
519
66317 items  Read more >>
Reader Comments
1
"Wang and Pan present an editorial that meaningfully extends the discussion of ERAS in elderly gastric cancer patients beyond ..."  [Read more]
"Wang and Pan present an editorial that meaningfully extends the discussion of ERAS in elderly gastric cancer patients beyond feasibility toward biologically grounded recovery. Building on prior evidence by Li et al. demonstrating the safety and protocol adherence of ERAS in older adults. The authors appropriately emphasize physiological heterogeneity, frailty, and resilience as key determinants of postoperative outcomes rather than chronological age alone. The proposed multidomain framework integrating nutritional inflammatory balance, circadian regulation, psychological resilience, and digital monitoring, offers an important conceptual advance. However, many of these strategies rely on resource intensive multidisciplinary teams, biomarker surveillance, and wearable technologies, which may limit generalizability outside high-volume or well-resourced centers. Future efforts may benefit from parallel development of simplified, scalable ERAS adaptations for elderly patients. Overall, this editorial provides a valuable roadmap for evolving ERAS from protocol compliance toward patient-centered, biologically informed recovery in an aging surgical population. "  [Collapse]
Wang G, Pan SJ. From feasibility to biological recovery: Reframing enhanced recovery pathways for elderly gastric cancer patients. World J Gastroenterol 2026; 32(7): 116264
2
"This Editorial thoroughly explores the field of AI use in diagnostic radiology. It provides a complete overview of the potential and ..."  [Read more]
"This Editorial thoroughly explores the field of AI use in diagnostic radiology. It provides a complete overview of the potential and the current applications of AI in the field with great potential, strong diagnostic performance but in my opinion it does spotlight with the due consideration the potential drawbacks coming from the extensive use of AI in the clinical field. The enthusiasm generated from the high precision and performance and the consequent advantages in terms of resource and time save for operators outpaced evaluation of broader consequences. Concerns include trainee deskilling, automation bias, unclear medicolegal accountability, and inequitable access due to infrastructure demands. The authors emphasize that technical accuracy alone is insufficient and call for longitudinal studies, training models that preserve independent reasoning, and deployment strategies that address equity. Without systematic assessment of professional, clinical, and societal impacts, AI adoption risks being driven by non-evidence-based factors. "  [Collapse]
He ZX, Wang J, Yang JS. Expanding the applications of artificial intelligence in emergency radiology: Advancing precision medicine and resource efficiency. World J Radiol 2026; 18(1): 117814
3
"This study demonstrates that presenilin-1 (PS-1) is significantly associated with β-catenin activation, PTEN phosphorylation, advanced ..."  [Read more]
"This study demonstrates that presenilin-1 (PS-1) is significantly associated with β-catenin activation, PTEN phosphorylation, advanced tumor stage, and poor survival in gastric cancer. The combination of clinical data and functional assays strengthens the evidence for the PS-1/β-catenin/p-PTEN axis in promoting invasion and metastasis. These findings highlight a potential therapeutic target for gastric cancer treatment. "  [Collapse]
Lin X, Lin GF, Gu FT, Li YL. Increasing expression of presenilin 1, β-catenin, and p-PTEN and its regulatory roles on cell invasion in gastric cancer. World J Gastrointest Oncol 2026; 18(2): 115689
4
"In this paper, the tumor indicators of patients with gastric cancer after operation were detected and analyzed. It was found that ..."  [Read more]
"In this paper, the tumor indicators of patients with gastric cancer after operation were detected and analyzed. It was found that CEA and AFP were closely related to the recurrence of gastric cancer, which provided a good basis for judging the health level of patients with gastric cancer after operation. But it also needs the support of large-scale clinical data. At the same time, patients with gastric cancer need more tumor indicators to explore a better combination for judging the prognosis of patients with gastric cancer. "  [Collapse]
Duan XX, Yu X, Zhou L. Timeliness of postoperative serum carcinoembryonic antigen monitoring for predicting recurrence after gastric cancer surgery. World J Gastrointest Surg 2026; 18(1): 114309
5
"Dear Editor, I am writing in response to your invitation to comment on the prospective study by Güneş et al., entitled “Diagnostic ..."  [Read more]
"Dear Editor, I am writing in response to your invitation to comment on the prospective study by Güneş et al., entitled “Diagnostic value of interleukin-8 in colon cancer,” published in your esteemed journal. The authors provide valuable data reinforcing the role of interleukin-8 (IL-8) as an independent diagnostic biomarker in colon adenocarcinoma. Their work rightly concludes that IL-8 holds promise, particularly as part of a multi-marker panel. I would like to extend this discussion by contextualizing IL-8 within the current, rapidly evolving biomarker landscape of colorectal cancer (CRC), as recently elaborated in an editorial on this topic. The future of CRC management lies in a dynamic, multi-layered biomarker strategy that integrates three key pillars: 1) Mismatch repair (MMR) status to dictate therapeutic class (chemotherapy vs. immunotherapy); 2) Perioperative carcinoembryonic antigen (CEA) for immediate risk stratification, especially within microsatellite stable (MSS) disease; and 3) Postoperative circulating tumor DNA (ctDNA) as a dynamic tool to guide treatment intensity and de-escalation, as definitively demonstrated by the recent AGITG DYNAMIC-III trial. In this framework, the findings on IL-8 by Güneş et al. present a compelling opportunity. While its standalone diagnostic accuracy (AUC=0.68) is moderate, its independent predictive value suggests a distinct biological role, likely rooted in its pro-inflammatory and angiogenic functions. This positions IL-8 not as a replacement for the aforementioned pillars, but as a potential complementary element, particularly within the MSS cohort. Specifically, IL-8 could enhance the second pillar (risk stratification) by providing additional biological granularity. For instance, in MSS patients with normal or borderline CEA levels, an elevated IL-8 might signal a more aggressive tumor biology driven by inflammation, potentially identifying a subset that would benefit from closer surveillance or adjuvant therapy. Furthermore, given its link to angiogenesis and immune modulation, IL-8 merits investigation as a predictive biomarker for responses to anti-angiogenic therapies (e.g., bevacizumab) and possibly immunotherapy, even in MSS/pMMR tumors. Therefore, I propose that the next logical step for research, as inspired by both this study and the broader editorial perspective, is to evaluate IL-8 within integrated multi-marker panels. Combining IL-8 with CEA, ctDNA, and potentially other inflammatory markers (e.g., CRP) in algorithm-driven models could significantly improve diagnostic sensitivity, prognostic stratification, and predictive accuracy. This approach aligns perfectly with the paradigm of dynamic precision oncology, where multiple data streams are synthesized to guide personalized therapeutic navigation. I congratulate the authors on their contribution and thank you for the opportunity to share these perspectives, hoping they may stimulate further research into the integrative potential of IL-8 within the modern CRC biomarker ecosystem. Sincerely, Pr Nabil Ismaili Mohammed VI University of Sciences and Health (UM6SS), Mohammed VI Foundation of Sciences and Hrealth (FM6SS), Casablanca, Morocco, nismaili@um6ss.ma, 0000-0001-5786-5134 "  [Collapse]
Güneş G, Fırat Oğuz E, Kayılıoğlu I, Dinç T. Diagnostic value of interleukin-8 in colon cancer: Prospective, case-control study. World J Gastrointest Surg 2026; 18(1): 115444
6
"Systemic antifungal therapy is the backbone of treatment for invasive fungal infections, but it carries an under-recognized burden ..."  [Read more]
"Systemic antifungal therapy is the backbone of treatment for invasive fungal infections, but it carries an under-recognized burden of endocrine and physiological toxicity. The review by Thakkar et al. (2026) provides an important framework for understanding how these agents affect human cytochrome P450 enzymes and renal function, leading to adrenal insufficiency, mineralocorticoid excess, and electrolyte abnormalities. This review deserves recognition, and adding a global perspective to it could provide new recommendations. If possible, I would like to submit a letter addressing this perspective. "  [Collapse]
Thakkar S, Kantroo V, Nagendra L, Dutta D, Kamrul-Hasan ABM, Kalra S, Bhattacharya S. Endocrine consequences of antifungal therapy: A missed entity. World J Clin Cases 2026; 14(2): 117140
7
"I read with interest the study comparing the ASGE lexicon and the AGREE classification for adverse events in gastrointestinal ..."  [Read more]
"I read with interest the study comparing the ASGE lexicon and the AGREE classification for adverse events in gastrointestinal endoscopy. The authors are to be commended for their rigorous analysis of a large institutional registry and for highlighting the conceptual differences between two widely used adverse event frameworks. The high concordance observed between ASGE and AGREE confirms that both systems are robust for capturing clinically significant complications. However, the discordance noted for transient cardiorespiratory and sedation-related events raises an important interpretive issue. The ASGE lexicon intentionally captures such occurrences as “incidents,” supporting quality improvement and preventive strategies, whereas AGREE excludes many of these events by design, prioritising clinical consequence and post-procedural intervention. While this approach improves specificity, it may inadvertently narrow the safety signal. From a patient-centred perspective, events such as inadequate sedation, procedural discomfort, or transient hypoxia—although self-limiting—can significantly influence patient-reported experience, satisfaction, and trust in endoscopic services. These experiential harms may not require escalation of care yet remain meaningful to patients and may affect willingness for repeat procedures. Their exclusion from adverse event datasets risks underestimating quality concerns that are increasingly relevant in value-based care. The study also underscores that adverse event classification represents only one dimension of endoscopy quality. Domains such as procedural appropriateness, missed or delayed diagnoses, bowel preparation adequacy, photodocumentation quality, scheduling delays, and patient-initiated procedure termination are not captured by adverse event frameworks but are integral to comprehensive quality assessment. In summary, while standardised adverse event classification remains essential for benchmarking and safety governance, it should be complemented by patient-reported experience measures and broader quality indicators. A multidimensional framework integrating safety, experience, and appropriateness may better align endoscopy quality metrics with contemporary patient-centred practice. "  [Collapse]
Corsi O, Martinez R, Aguirre J, Friedrich I, Galeno V, Jimenez V, Briones P, Díaz LA, Espino A, Vargas JI. Application of a novel adverse event classification scale in a Latin American gastrointestinal endoscopy unit. World J Gastrointest Endosc 2026; 18(1): 111384
8
"This minireview provides a timely and balanced synthesis of the evolving role of endoscopic ultrasound-guided radiofrequency ablation ..."  [Read more]
"This minireview provides a timely and balanced synthesis of the evolving role of endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) in the management of pancreatic neuroendocrine tumors (pNETs). The authors appropriately frame EUS-RFA as a promising yet still selective therapeutic option, and the “lights and shadows” construct is effective in highlighting both its clinical potential and its current limitations A major strength of the article lies in its comprehensive collation of published clinical experience across functioning and non-functioning pNETs. The tabulated summaries are particularly valuable for readers seeking an overview of technical success, clinical response, and adverse event profiles. Importantly, the authors avoid overstating efficacy and consistently acknowledge the predominance of retrospective series, limited follow-up durations, and heterogeneity in response definitions—an intellectua rigour that strengthens the manuscript. From a conceptual standpoint, the review highlights a key paradigm shift: EUS-RFA is no longer merely a salvage or palliative modality, but a potential intermediate option within the “grey zone” of small, low-grade pNETs, especially in patients unfit for surgery or those prioritizing minimally invasive approaches. This raises an important clinical question not fully resolved in current guidelines—whether EUS-RFA should eventually be positioned as a disease-modifying therapy rather than an alternative to surveillance. The discussion on radiological response assessment underscores a critical unmet need in the field. The lack of standardized imaging endpoints, timing of follow-up, and correlation with long-term oncologic outcomes limits meaningful comparison across studies. Future consensus on response metrics—possibly integrating contrast-enhanced harmonic EUS, cross-sectional imaging, and biochemical markers—would significantly enhance interpretability and clinical adoption. Finally, the article appropriately calls attention to procedural standardization and risk mitigation, particularly regarding pancreatitis prevention and proximity to the main pancreatic duct. These considerations will be central if EUS-RFA is to move beyond expert centers into broader clinical practice. Overall, this review serves as a valuable reference for gastroenterologists, endosonographers, and multidisciplinary teams managing pNETs. It also clearly delineates the research priorities required before EUS-RFA can be fully integrated into evidence-based treatment algorithms. "  [Collapse]
Tringali A, Caiazzo A. Role of endoscopic ultrasound in the treatment of pancreatic neuroendocrine tumors: Lights and shadows of endoscopic ultrasound-guided radiofrequency ablation. World J Gastrointest Endosc 2026; 18(1): 113617
9
"Commentary: Clinical Considerations in Immunocompromised Patients With Edwardsiella tarda–Associated Spontaneous Bacterial Peritonitis ..."  [Read more]
"Commentary: Clinical Considerations in Immunocompromised Patients With Edwardsiella tarda–Associated Spontaneous Bacterial Peritonitis The case report by Usuda et al., recently published in the World Journal of Clinical Cases, represents a notable contribution to clinical microbiology by documenting, to the best of current knowledge, the first reported case of spontaneous bacterial peritonitis (SBP) caused by Edwardsiella tarda in an immunocompromised patient undergoing dialysis [1].This report substantially expands the recognized infectious spectrum in patients with end-stage renal disease (ESRD) and underscores the need for heightened clinical awareness of atypical and opportunistic pathogens in this vulnerable population. One particularly commendable aspect of this report is the authors’ detailed discussion of the virulence mechanisms of E. tarda. The organism’s capacity to survive and replicate within macrophages plays a pivotal role in its pathogenicity, especially in hosts with compromised cellular immunity [2,3]. In the present case, the coexistence of diabetic nephropathy and long-term dialysis likely created a permissive immunological milieu that facilitated this opportunistic infection. Such intracellular persistence provides a plausible explanation for the severe and insidious clinical course observed, even in the absence of classical epidemiological exposures such as raw seafood consumption or contact with freshwater environments. Equally noteworthy is the authors’ adherence to principles of antimicrobial stewardship. The stepwise transition from empirical broad-spectrum therapy with cefmetazole to targeted, de-escalated treatment using cefalexin—guided by comprehensive antimicrobial susceptibility testing (Table 3)—offers a valuable therapeutic reference for clinicians managing similarly rare infections. Nevertheless, building on the authors’ insightful acknowledgment of the limitations surrounding “ascites culture conversion,” I would like to propose a more structured and rigorous framework for defining treatment endpoints in such high-risk cases. While clinical and symptomatic improvement remains an essential marker of response, it may be insufficient when dealing with pathogens such as E. tarda, which possess the ability to persist intracellularly [4,5]. Accordingly, I suggest an integrated “imaging-to-microbiology” strategy prior to antibiotic discontinuation. First, advanced imaging modalities—such as abdominal computed tomography or high-resolution ultrasonography—should be systematically incorporated to objectively assess the resolution of ascites. Complete radiological absorption of ascitic fluid would substantially strengthen the clinical justification for treatment cessation. Conversely, if residual ascites is detected, even in minimal or loculated forms, reliance on systemic inflammatory markers such as C-reactive protein or leukocyte counts alone may be misleading. Given the organism’s persistence potential [3], repeat diagnostic paracentesis should be strongly considered to confirm microbiological eradication. This dual confirmation—radiological and microbiological—would provide a more robust and evidence-based rationale for terminating antimicrobial therapy [6], thereby reducing the risk of relapse in immunocompromised patients. In conclusion, while this case report fills an important gap in the current literature, it also highlights the need to refine discharge and treatment-completion criteria for rare causes of SBP. Adoption of an imaging-guided microbiological confirmation strategy may enhance the precision of clinical decision-making and ultimately improve long-term outcomes in patients with complex comorbidities. 参考文献 [1]Usuda D , Furukawa D, Imaizumi R et al. Spontaneous bacterial peritonitis due to Edwardsiella tarda in an immuno-compromised dialysis patient: A case report and review of literature. World J Clin Cases 2026,6; 14(1): 115102. [2][2]Qin L, Li F, Wang X, Sun Y, Bi K, Gao Y. Proteomic analysis of macrophage in response to Edwardsiella tarda-infection. Microb Pathog, 2017; 111: 86-93 [RCA] [PMID: 28826764 DOI: 10.1016/j.micpath.2017.08.028] [3]Zhang L, Ni C, Xu W, Dai T, Yang D, Wang Q, Zhang Y, Liu Q. Intramacrophage Infection Reinforces the Virulence of Edwardsiella tarda. J Bacteriol 2016; 198: 1534-1542 [RCA] [PMID: 26953340 DOI: 10.1128/JB.00978-15] [4]An L, Chan JL, Nguyen M, Yang S, Deville JG. Case Report: Disseminated Edwardsiella tarda infection in an immunocompromised patient. Front Cell Infect Microbiol 2023; 13: 1292768 [RCA] [PMID: 38053529 DOI: 10.3389/fcimb.2023.1292768] [5]Matsukawa H, Usuda D, Takami H, Nomura T, Sugita M. A Case of Edwardsiella tarda Infection With Iliopsoas Abscess Following Acute Pyelonephritis. Cureus 2024; 16: e58868 [RCA] [PMID: 38800258 DOI: 10.7759/cureus.58868] [6]A Rimola , G García-Tsao, M Navasa, L J Piddock, R Planas, B Bernard, J M Inadomi. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol, 2000; 32(1):142-53[RCA][PMID: 10673079 DOI: 10.1016/s0168-8278(00)80201-9] "  [Collapse]
Usuda D, Furukawa D, Imaizumi R, Ono R, Kaneoka Y, Nakajima E, Kato M, Sugawara Y, Shimizu R, Inami T, Kawai K, Matsubara S, Tanaka R, Suzuki M, Shimozawa S, Hotchi Y, Osugi I, Katou R, Ito S, Mishima K, Kondo A, Mizuno K, Takami H, Komatsu T, Nomura T, Sugita M. Spontaneous bacterial peritonitis due to Edwardsiella tarda in an immuno-compromised dialysis patient: A case report and review of literature. World J Clin Cases 2026; 14(1): 115102
10
"This paper presents a systematic retrospective analysis of the incidence and clinical significance of gallstones and gallbladder wall ..."  [Read more]
"This paper presents a systematic retrospective analysis of the incidence and clinical significance of gallstones and gallbladder wall thickening in patients with liver cirrhosis, offering valuable clinical observations for practitioners. The study clearly indicates that the prevalence of gallbladder abnormalities—including gallstones and asymptomatic wall thickening—is significantly higher in patients with cirrhosis, especially in the decompensated stage, compared to the general population. This finding aligns with previous research and further supports the pivotal role of portal hypertension and hepatic dysfunction in the development of gallbladder pathology. Notably, the authors emphasize that these imaging findings are often related to cirrhosis itself rather than being indicators of acute cholecystitis. This distinction is clinically important, as it can help prevent unnecessary interventions—such as misdiagnosis and surgery for presumed acute cholecystitis—particularly in asymptomatic individuals. Moreover, the study suggests that gallbladder abnormalities correlate more strongly with the decompensated state of cirrhosis than with its etiology, providing a fresh perspective on the mechanisms underlying gallbladder changes in these patients. However, several limitations should be acknowledged. First, the retrospective design and single-center sample may limit the generalizability of the results. Second, the study lacks in-depth analysis of subgroups based on the etiology of cirrhosis, leaving it unclear whether findings differ notably in non-alcoholic liver disease patients. Finally, potential influencing factors such as gallbladder motility and medication use were not systematically evaluated, even though they may contribute to wall thickening and stone formation. Overall, this paper offers practical clinical insights into the imaging assessment of the gallbladder in cirrhotic patients. Future prospective, multicenter studies incorporating more pathophysiological parameters—such as gallbladder motility and bile composition—could help further elucidate the complex relationship between cirrhosis and gallbladder disorders and contribute to optimized clinical decision-making. "  [Collapse]
Tsankof A, Protopapas AA, Kyritsi V, Gogou C, Kyziroglou M, Papathanasiou E, Chatzikosma C, Michalopoulos A, Savopoulos C, Protopapas AN. Gallstones and gallbladder wall thickening in patients with cirrhosis: Prevalence and clinical impact. World J Clin Cases 2026; 14(1): 114043
11
"This meta-analysis systematically retrieved and synthesized evidence from 30 randomized controlled trials (RCTs) involving nearly ..."  [Read more]
"This meta-analysis systematically retrieved and synthesized evidence from 30 randomized controlled trials (RCTs) involving nearly 17,000 patients, providing the most comprehensive assessment to date on the efficacy of indomethacin for preventing post-ERCP pancreatitis (PEP). It offers valuable, up-to-date evidence-based references for clinical practice, and the authors' efforts are highly commendable. Nevertheless, while acknowledging its contributions, two critical methodological limitations must be highlighted, which may compromise the interpretation and generalizability of its findings. The present commentary aims to identify two key methodological flaws in this meta-analysis that seriously undermine the statistical validity and clinical interpretability of its results. First, the authors inappropriately disaggregated seven multi-arm randomized controlled trials into multiple independent pairwise comparisons for inclusion in the analysis. This practice directly violates the core assumption of data independence in meta-analyses: different comparison groups derived from the same trial are correlated due to the shared control arm. Treating these as independent samples artificially inflates the total sample size, misestimates the weight of each study, and leads to an inappropriate narrowing of confidence intervals, thereby increasing the risk of Type I or Type II errors. Second, the definition of the "control group" in the study encompasses interventions with extremely high clinical heterogeneity, including placebo, normal saline, other active medications (e.g., diclofenac, somatostatin), and invasive procedures (e.g., pancreatic duct stenting). Pooling these controls with vastly different mechanisms of action and therapeutic efficacies renders the reported pooled relative risk (RR = 0.85) clinically meaningless. Furthermore, the high heterogeneity observed (I² = 79%) is most likely attributable to this flawed methodological design. In summary, the aforementioned issues cast doubt on the statistical credibility of the primary conclusion—that "indomethacin does not significantly reduce the incidence of PEP"—and also make it difficult to provide a reasonable clinical interpretation for practice. Given that this review incorporates multiple interrelated interventions for comparison, network meta-analysis would represent a more appropriate methodological framework. It can rigorously integrate data from multi-arm trials and simultaneously evaluate the relative efficacy of all relevant preventive strategies. "  [Collapse]
Tian F, Huang ZC, Khizar H, Qiu K. Efficacy of indomethacin for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: A comprehensive meta-analysis of randomized controlled trials. World J Gastroenterol 2026; 32(1): 113232
12
"This meta-analysis systematically retrieved and synthesized evidence from 30 randomized controlled trials (RCTs) involving nearly ..."  [Read more]
"This meta-analysis systematically retrieved and synthesized evidence from 30 randomized controlled trials (RCTs) involving nearly 17,000 patients, providing the most comprehensive assessment to date on the efficacy of indomethacin for preventing post-ERCP pancreatitis (PEP). It offers valuable, up-to-date evidence-based references for clinical practice, and the authors' efforts are highly commendable. Nevertheless, while acknowledging its contributions, two critical methodological limitations must be highlighted, which may compromise the interpretation and generalizability of its findings. The present commentary aims to identify two key methodological flaws in this meta-analysis that seriously undermine the statistical validity and clinical interpretability of its results. First, the authors inappropriately disaggregated seven multi-arm randomized controlled trials into multiple independent pairwise comparisons for inclusion in the analysis. This practice directly violates the core assumption of data independence in meta-analyses: different comparison groups derived from the same trial are correlated due to the shared control arm. Treating these as independent samples artificially inflates the total sample size, misestimates the weight of each study, and leads to an inappropriate narrowing of confidence intervals, thereby increasing the risk of Type I or Type II errors. Second, the definition of the "control group" in the study encompasses interventions with extremely high clinical heterogeneity, including placebo, normal saline, other active medications (e.g., diclofenac, somatostatin), and invasive procedures (e.g., pancreatic duct stenting). Pooling these controls with vastly different mechanisms of action and therapeutic efficacies renders the reported pooled relative risk (RR = 0.85) clinically meaningless. Furthermore, the high heterogeneity observed (I² = 79%) is most likely attributable to this flawed methodological design. In summary, the aforementioned issues cast doubt on the statistical credibility of the primary conclusion—that "indomethacin does not significantly reduce the incidence of PEP"—and also make it difficult to provide a reasonable clinical interpretation for practice. Given that this review incorporates multiple interrelated interventions for comparison, network meta-analysis would represent a more appropriate methodological framework. It can rigorously integrate data from multi-arm trials and simultaneously evaluate the relative efficacy of all relevant preventive strategies. "  [Collapse]
Ding Y, Wang CY, Pan YT, Wang YJ, Zhao AG, Wen HZ. Scutellaria baicalensis Georgi as a potential therapeutic drug intervention in ulcerative colitis: Mechanisms of action and clinical trials. World J Gastroenterol 2026; 32(1): 114558
13
"I read the excellent paper by Rajak et al. The review is organized and precisely addresses the role of microplastics in inducing ..."  [Read more]
"I read the excellent paper by Rajak et al. The review is organized and precisely addresses the role of microplastics in inducing metabolic-associated steatotic liver disease and its progression. The review raises a growing emergency: the relationship between air pollution and human health. This can be a stimulus for policymakers and international organizations to take concrete action. However, it should be remembered that a proper lifestyle can mitigate the negative impact of microplastics on the liver and human health in general. While waiting for long-term measures, this is information that can yield short-term results. On this issue, it will be my concern to send a letter to the editor. Sincerely, Gianni Testino "  [Collapse]
Rajak S, Shahi A, Yadav A, Medhe P, Sinha RA. Microplastics in metabolic dysfunction-associated steatotic liver disease: An emerging threat to liver health. World J Hepatol 2025; 17(12): 111198
14
"1.The article does not cover the temporal and spatial dynamic changes of inflammatory cytokines during the development of NSCLC, as ..."  [Read more]
"1.The article does not cover the temporal and spatial dynamic changes of inflammatory cytokines during the development of NSCLC, as well as how these changes affect the occurrence and development of drug resistance. For instance, are there any differences in the expression levels of inflammatory cytokines in the early stage, progression stage, and resistance stage of the tumor? Are their distributions different in various parts of the tumor (such as the primary lesion and metastatic lesion)? It is suggested to utilize techniques such as in situ hybridization and immunohistochemistry, combined with single-cell sequencing and spatial transcriptomics, to study the temporal and spatial dynamic changes of inflammatory cytokines in different development stages and different locations of NSCLC. By analyzing longitudinal samples of patients (such as before treatment, during treatment, and after resistance), the dynamic change patterns of inflammatory cytokines during the process of drug resistance can be revealed. 2. Although IL-6R blockade shows the effect of reversing drug resistance, single-target therapy may have limitations in efficacy or the risk of drug resistance escape. It is suggested to explore IL-6/IL-8 dual-target inhibition in preclinical models, or to combine it with downstream pathway inhibitors (such as JAK/STAT, PI3K/AKT, NF-κB inhibitors) or immune checkpoint inhibitors to evaluate its synergistic anti-tumor effect and its remodeling effect on the tumor microenvironment, in order to provide theoretical basis for future clinical trials of combination therapy. "  [Collapse]
Calibasi-Kocal G. Inflammatory cytokine-associated cisplatin resistance in non-small cell lung cancer and re-sensitization through interleukin-6 receptor blockade. World J Clin Oncol 2025; 16(12): 114275
15
"Author: Priya Hazrah Professor, Department of Surgery, Lady Hardinge Medical College, New Delhi. Email: priyahazrah@gmail.com, ORCID ..."  [Read more]
"Author: Priya Hazrah Professor, Department of Surgery, Lady Hardinge Medical College, New Delhi. Email: priyahazrah@gmail.com, ORCID ID 0009-0008-1915-3978 Deborshi Sharma Director Professor Department of Surgey ABVIMS, New Delhi. Email: drdeborshi@gmail.com, ORCID ID 0000-0001-8251-8484 Sonali Mittal Assistant professor, Lady Hardinge Medical College, New Delhi Email: sonali.prachi@gmail.com, ORCID 0000-0002-6289-7656 Corresponding Author: Priya Hazrah Professor Department of Surgery, Lady Hardinge Medical College, New Delhi. Email: priyahazrah@gmail.com We read with tremendous interest your article entitled “Mastering the third space: Innovations in intramural endoscopic surgery for gastrointestinal disorders.” It was a very apt and concise review of commonly performed third space endoscopy (TSE) procedures, namely the C, Z, E, and G POEM (per oral endoscopic myotomy). Here, we would like to highlight other evolving procedures related to third space endoscopy and also the emerging concept of “fourth space endoscopy.” POETRE, peroral esophageal tunnelling for restoration of the esophagus, based on the principle of TSE, is an innovative technique of submucosal tunnelling proposed to be a useful therapeutic option in long-segment complete esophageal luminal obstruction in a few case series [1, 2]. PREM/PAEM (per rectal/per anal myotomy) is another novel use of TSE with limited exploration in patients with Hirschsprung’s disease [3]. STER (submucosal tunnelling endoscopic resection) and POET (peroral endoscopic excision of tumor) have been reported to be safe procedures for resection of extramucosal tumors in the upper gastrointestinal tract with acceptable complication rates vouched for in recent meta-analyses [4-7]. Further, TSE can be used to gain peritoneal access, as seen in POEM+F (POEM with fundoplication). Building upon the model of third space endoscopy is a forthcoming concept of fourth space endoscopy based on the technique of sub-serosal dissection for excision of extramucosal tumors in the upper gastrointestinal tract, like gastrointestinal stromal tumors, leiomyoma, hamartoma, etc., published in a limited case series [8]. The feasibility of using the principle of the fourth-space endoscopy procedure for vagotomy is investigational and has been reported currently in an anecdotal non-human study [9]. The fourth space is also utilized at times in POEM to enable a full-thickness myotomy [10]. References 1. Wagh MS, Draganov PV. Per-oral endoscopic tunneling for restoration of the esophagus: a novel endoscopic submucosal dissection technique for therapy of complete esophageal obstruction. Gastrointest Endosc. 2017 Apr;85(4):722-727. doi: 10.1016/j.gie.2016.08.035. Epub 2016 Sep 7. PMID: 27612924. 2. Félix C, Barreiro P, Rodrigues Azevedo J, Maia L, Küttner-Magalhães R, Pedroto I, Chagas C. Per-oral endoscopic tunneling for restoration of the esophagus (POETRE) in the management of a complete esophageal obstruction. Endosc Int Open. 2021 Jul;9(7):E1084-E1085. doi: 10.1055/a-1463-3059. Epub 2021 Jun 17. PMID: 34222634; PMCID: PMC8211479. 3. Bapaye A, Dashatwar P, Biradar V, Biradar S, Pujari R. Initial experience with per-rectal endoscopic myotomy for Hirschsprung's disease: medium and long term outcomes of the first case series of a novel third-space endoscopy procedure. Endoscopy. 2021 Dec;53(12):1256-1260. doi: 10.1055/a-1332-6902. Epub 2021 Mar 2. PMID: 33291158. 4. Onimaru M, Inoue H, Bechara R, Tanabe M, Abad MRA, Ueno A, Shimamura Y, Sumi K, Ikeda H, Ito H. Clinical outcomes of per-oral endoscopic tumor resection for submucosal tumors in the esophagus and gastric cardia. Dig Endosc. 2020 Mar;32(3):328-336. doi: 10.1111/den.13471. Epub 2019 Jul 22. PMID: 31234231. 5. Peng W, Tan S, Huang S, Ren Y, Li H, Peng Y, Fu X, Tang X. Efficacy and safety of submucosal tunneling endoscopic resection for upper gastrointestinal submucosal tumors with more than 1-year' follow-up: a systematic review and meta-analysis. Scand J Gastroenterol. 2019 Apr;54(4):397-406. doi: 10.1080/00365521.2019.1591500. Epub 2019 Mar 29. PMID: 30925071. 6. Song S, Wang X, Zhang S, Li Y, Zhang X, Chu X. Efficacy and complications of submucosal tunneling endoscopic resection for upper gastrointestinal submucosal tumors and exploration for influencing factors. Z Gastroenterol. 2018 Apr;56(4):365-373. English. doi: 10.1055/s-0043-123765. Epub 2018 Jan 18. PMID: 29346827. 7. Cao B, Lu J, Tan Y, Liu D. Efficacy and safety of submucosal tunneling endoscopic resection for gastric submucosal tumors: a systematic review and meta-analysis. Rev Esp Enferm Dig. 2021 Jan;113(1):52-59. doi: 10.17235/reed.2020.6989/2020. PMID: 33222480. 8. Liu F, Zhang S, Ren W, Yang T, Lv Y, Ling T, Zou X, Wang L. The fourth space surgery: endoscopic subserosal dissection for upper gastrointestinal subepithelial tumors originating from the muscularis propria layer. Surg Endosc. 2018 May;32(5):2575-2582. doi: 10.1007/s00464-017-5985-z. Epub 2017 Dec 20. PMID: 29264757. 9. Kadkhodayan K, Irani S. Endoscopic truncal vagotomy. Exploring the fourth space. A technical feasibility study in a porcine model. VideoGIE. 2025 Mar 4;10(7):340-344. doi: 10.1016/j.vgie.2025.02.012. PMID: 40642399; PMCID: PMC12237756. 10. Jiang T, Yang Y, Luo W. Application of the fourth space in peroral endoscopic myotomy (POEM) surgery for achalasia. Rev Esp Enferm Dig. 2025 Jun 27. doi: 10.17235/reed.2025.11331/2025. Epub ahead of print. PMID: 40575899. "  [Collapse]
Restrepo-Rodas G, Rodriguez J. Mastering the third space: Innovations in intramural endoscopic surgery for gastrointestinal disorders. World J Gastrointest Endosc 2025; 17(12): 111206
16
"This article addresses an important and timely topic: differentiation-based strategies for colorectal cancer (CRC) therapy using ..."  [Read more]
"This article addresses an important and timely topic: differentiation-based strategies for colorectal cancer (CRC) therapy using natural products. The authors present a comprehensive in vitro study suggesting that Ferula assafoetida (FA) induces differentiation and apoptosis in Caco-2 colon cancer cells, potentially via activation of the JNK/MAPK pathway. As a reader, the work is interesting, methodologically broad, and conceptually aligned with current interests in natural compound–based cancer therapeutics, although certain conceptual and interpretative gaps limit its translational impact. As a reader, I would regard this article as a useful exploratory study that justifies further mechanistic, protein-level, and in vivo investigations, rather than a conclusive demonstration of FA as a differentiation therapy for CRC. "  [Collapse]
Abdelsalam HM, Abdelghany AM, Ahmed WA, Diab AA, Abdellateif MS. Ferula assafoetida induced colon cancer cells differentiation through JNK/MAPK signalling pathway activation. World J Exp Med 2025; 15(4): 110757
17
"his retrospective study by Cooper et al. provides a valuable comparison of endoscopic band ligation (EBL) and endoscopic thermal ..."  [Read more]
"his retrospective study by Cooper et al. provides a valuable comparison of endoscopic band ligation (EBL) and endoscopic thermal therapy (ETT) as initial treatments for nodular gastric antral vascular ectasia (GAVE), a rare and challenging subtype. The analysis of 37 patients demonstrates that EBL outperforms ETT, with significantly higher clinical remission rates (90% vs. 69%, P=0.041), shorter treatment intervals (172 vs. 928 days, P=0.013), and fewer required endoscopic sessions (1.95 vs. 5.56, P=0.009), supported by improved hemoglobin levels and reduced transfusions. The findings robustly advocate for EBL as a first-line approach due to its efficiency and lower treatment burden. However, limitations include the small sample size, single-center design, and retrospective nature, which may affect generalizability. Despite this, the study fills a critical gap in nodular GAVE management and underscores the need for prospective multicenter trials to validate EBL's superiority and optimize clinical protocols. "  [Collapse]
Cooper JA, Statham E, Holyfield A, Shoreibah MG, Peter S. Initial treatment approaches for nodular gastric antral vascular ectasia: A comparison of endoscopic band ligation and thermal therapies. World J Gastrointest Endosc 2025; 17(12): 111872
18
"The minireview by El Dada et al. offers a timely synthesis of endoscopic ultrasound (EUS)-guided coil embolization for gastric varices ..."  [Read more]
"The minireview by El Dada et al. offers a timely synthesis of endoscopic ultrasound (EUS)-guided coil embolization for gastric varices (GVs), highlighting its potential as a safer, precise alternative to traditional therapies like cyanoacrylate injection. Strengths include systematic comparisons with meta-analytic data (e.g., 96.7% obliteration rate for EUS-coil/cyanoacrylate vs. 70.6% for cyanoacrylate alone), practical technical details (coil selection, Doppler confirmation), real-world case illustrations, and cost-effectiveness analysis (1,831vs.11,000 hospitalization). However, limitations persist: reliance on retrospective/single-center data, absence of randomized controlled trials (RCTs) against TIPS/BRTO, and lack of long-term (>5 years) rebleeding/complication data (e.g., coil migration). The authors appropriately call for multicenter RCTs to standardize protocols, explore material combinations, and integrate predictive biomarkers. Despite gaps, the review compellingly argues for EUS-coil’s inclusion in GV guidelines, serving as a valuable reference for advancing therapeutic endoscopy with balanced analysis of efficacy, safety, and accessibility. "  [Collapse]
El Dada A, El Khoury M, Stephan P, Nehme F. Endoscopic ultrasound-guided coil embolization for gastric varices: A promising alternative to traditional therapies. World J Gastrointest Endosc 2025; 17(12): 110168
19
"Name of Journal: World Journal of Gastroenterology Manuscript Type: LETTER TO THE EDITOR Dialister-Associated Succinate Dysregulation ..."  [Read more]
"Name of Journal: World Journal of Gastroenterology Manuscript Type: LETTER TO THE EDITOR Dialister-Associated Succinate Dysregulation in Crohn’s Disease: Clinical and Therapeutic Implications 1Fotios S. Fousekis, 1Konstantinos H. Katsanos, 2Konstantinos Vlachos, 2Georgios D. Lianos 1Department of Gastroenterology, University Hospital of Ioannina, University of Ioannina Ioannina, Greece 2Department of Surgery, University Hospital of Ioannina, University of Ioannina, Greece Corresponding author: Fotios S. Fousekis, MD, PhD, Department of Gastroenterology, University Hospital of Ioannina, University of Ioannina Ioannina, Greece, email: fotisfous@gmail.com Abstract Growing evidence suggests that altered gut microbiota–derived succinate metabolism plays an important role in Crohn’s disease activity and postoperative recurrence. Particular emphasis is placed on Dialister, a gut bacterial genus that consumes succinate inefficiently, potentially leading to its accumulation and increased intestinal inflammation. Elevated succinate may impair immune regulation and enhance inflammatory signaling through SUCNR1 activation and hypoxia-inducible factor-1α stabilization. Recent findings identifying specific Dialister strains associated with postoperative recurrence provide new insight into disease monitoring and risk stratification. Although the study offers an integrative view linking microbial composition, metabolism, and inflammation, further validation using direct metabolomic and shotgun metagenomic approaches is needed. Overall, succinate appears to be a promising biomarker and therapeutic target, supporting future microbiota- and metabolism-based strategies for the management of inflammatory bowel disease. Key words: Crohn’s disease; Inflammatory bowel disease; Gut microbiota; Succinate; Dialister; Postoperative recurrence Core tip Accumulation of the microbial metabolite succinate is increasingly recognized as a key driver of inflammation in Crohn’s disease. Recent evidence links Dialister enrichment to impaired succinate clearance, disease activity, and postoperative recurrence, highlighting succinate as a promising biomarker and therapeutic target in inflammatory bowel disease. To the editor Dialister, an anaerobic Gram-negative genus of the human gut microbiome, has gained clinical interest due to its role in succinate metabolism. While capable of utilizing succinate as a substrate for propionate production, Dialister exhibits relatively slow consumption rates compared with efficient succinate consumers such as Phascolarctobacterium. This inefficiency may result in elevated luminal succinate levels, particularly in the context of inflammatory bowel disease (IBD) (1). Succinate accumulation may disrupt regulatory T cell (Treg) function by promoting FOXP3 degradation, thereby reducing immune tolerance and further amplifying inflammation (2). Furthermore, elevated succinate stabilizes hypoxia-inducible factor-1α (HIF-1α) by inhibiting prolyl hydroxylase activity, which prevents HIF-1α degradation and leads to enhanced inflammatory gene expression and perpetuation of tissue injury, particularly in IBD (3). We read with great interest the recently published article by Boronat-Toscano and colleagues on Dialister-driven succinate accumulation and its association with disease activity and postoperative recurrence in Crohn’s disease (4). This study offers valuable insights into a rapidly growing field of research that links gut microbiota, host metabolism, and inflammation. It positions succinate not just as a metabolic by-product but also as a functional biomarker and potential therapeutic target. One of the major strengths of this work is its integrative, multi-level approach, which combines clinical and biochemical measures of disease activity, such as the Harvey–Bradshaw Index, C-reactive protein, and fecal calprotectin, with gut microbiome profiling using 16S rRNA sequencing and host molecular markers related to succinate signaling, specifically the expression of the succinate receptor SUCNR1 (4). Notably, this study highlights specific Dialister operational taxonomic units (OTUs) in the intestinal mucosa that correlate with the risk and severity of postoperative recurrence. This goes beyond existing knowledge by identifying strain-level microbial signatures with potential predictive value, suggesting that variability within Dialister is vital for patient stratification and disease progression after surgery. The authors also propose a mechanism for succinate accumulation in Crohn's disease, involving the downregulation of NADH dehydrogenase and the upregulation of fumarate reductase and succinate transporters. This metabolic shift enhances succinate production and export by the gut microbiota (4). Despite these strengths, we would like to highlight several issues that merit further discussion. The functional analysis of the gut microbiome is based on predictive approaches (PICRUSt2) rather than on direct measurements of metabolic fluxes or shotgun metagenomic sequencing. Validation of these predictions is essential for robust conclusions. Targeted metabolomic analyses, using mass spectrometry or nuclear magnetic resonance, allow for direct quantification of metabolites as succinate and can confirm the functional activity of predicted pathways (5). In addition shotgun metagenomic sequencing may provide a more comprehensive and direct assessment of the genetic potential for metabolic pathways, including those involved in succinate production and consumption, by sequencing all microbial DNA present in a sample (6). These findings also open important avenues for future research and therapeutic development in inflammatory bowel disease. Given the central role of succinate in promoting intestinal inflammation through SUCNR1 activation and HIF-1α stabilization, strategies aimed at reducing succinate accumulation or blocking its downstream signaling pathways warrant further investigation. Microbiota-targeted interventions, including dietary fiber enrichment, prebiotics, and probiotics designed to enhance the abundance of efficient succinate-consuming bacteria such as Phascolarctobacterium, represent a particularly promising approach, as preclinical studies have demonstrated their ability to lower succinate levels, attenuate inflammatory signaling, and restore epithelial barrier integrity (7). Avoiding supplementation of the diet with refined inulin may be considered, as evidence from mouse models suggests that it can induce abnormal succinate accumulation in the intestinal lumen, thereby contributing to colonic inflammation (8). In parallel, pharmacological inhibition of SUCNR1 using small-molecule antagonists, as well as interventions targeting HIF-1α stabilization, may offer complementary strategies to suppress succinate-driven inflammation (9, 10). Huo et al. demonstrated that the SUCNR1 inhibitor NF-56-EJ40 may suppress glycolysis in intestinal epithelial cells and attenuates Th17-mediated inflammation in a dextran sodium sulfate–induced mouse model of ulcerative colitis. Treatment reduced pro-inflammatory cytokine production, improved epithelial barrier integrity, and alleviated colonic injury, supporting SUCNR1 antagonism as a therapeutic strategy targeting both metabolic and immune pathways (7). Consistently, genetic deletion of SUCNR1 in mice protected against both acute colitis and intestinal fibrosis, while in human fibroblasts derived from Crohn’s disease patients, succinate increased SUCNR1 expression and promoted inflammatory and fibrotic markers that were effectively reversed by SUCNR1 blockade (11). While these approaches are supported by growing mechanistic and translational evidence, well-designed clinical trials will be essential to determine their efficacy and safety in patients with IBD. Conclusion The study conducted by Boronat-Toscano et al. enhances the understanding of how microbiota-driven metabolic dysregulation relates to Crohn’s disease by identifing succinate and Dialister-associated microbial signatures associated as important factors that influence disease activity and the likelihood of postoperative recurrence. These findings support the use of succinate-related biomarkers in future risk assessment and postoperative monitoring strategies. Additionally, they provide a strong biological basis for therapeutic interventions that target succinate metabolism or SUCNR1-mediated signaling. Overall, this study marks a crucial step towards developing metabolically informed, microbiome-based precision medicine for IBD. Author contributions: Fousekis FS wrote the original draft; Lianos GD contributed to conceptualization, writing, reviewing and editing; Katsanos KH and Vlachos K participated in drafting the manuscript; and all authors have read and approved the final version of the manuscript. References 1. Anthamatten L, von Bieberstein PR, Menzi C, Zund JN, Lacroix C, de Wouters T, Leventhal GE. Stratification of human gut microbiomes by succinotype is associated with inflammatory bowel disease status. Microbiome. 2024;12(1):186. PMID: 39350289 PMCID: PMC11441152 DOI: 10.1186/s40168-024-01897-8 2. Wang H, Hu D, Cheng Y, Gao Q, Liu K, Mani NL, Tang AY, Iyer R, Gao B, Zhou Q, Yu Q, Weinberg SE, Zhang X, Cong Y, Dulai PS, Zhang Y, Liu Z, Fang D. Succinate drives gut inflammation by promoting FOXP3 degradation through a molecular switch. Nat Immunol. 2025;26(6):866-80. PMID: 40457062 PMCID: PMC12399925 DOI: 10.1038/s41590-025-02166-y 3. Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, Goel G, Frezza C, Bernard NJ, Kelly B, Foley NH, Zheng L, Gardet A, Tong Z, Jany SS, Corr SC, Haneklaus M, Caffrey BE, Pierce K, Walmsley S, Beasley FC, Cummins E, Nizet V, Whyte M, Taylor CT, Lin H, Masters SL, Gottlieb E, Kelly VP, Clish C, Auron PE, Xavier RJ, O'Neill LAJ. Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha. Nature. 2013;496(7444):238-42. PMID: 23535595 PMCID: PMC4031686 DOI: 10.1038/nature11986 4. Boronat-Toscano A, Queipo-Ortuño MI, Monfort-Ferré D, Suau R, Vañó-Segarra I, Valldosera G, Cepero C, Astiarraga B, Clua-Ferré L, Plaza-Andrade I, Aranega-Martín L, Cabrinety L, Abadia de Barbarà C, Castellano-Castillo D, Moliné A, Caro A, Domènech E, Sánchez-Herrero JF, Benaiges-Fernandez R, Fernández-Veledo S, Vendrell J, Ginés I, Sumoy L, Manyé J, Menacho M, Serena C. Dialister-driven succinate accumulation is associated with disease activity and postoperative recurrence in Crohn's disease. World J Gastroenterol. 2025;31(45):112618. PMID: 41378335 PMCID: PMC12687013 DOI: 10.3748/wjg.v31.i45.112618 5. Han S, Van Treuren W, Fischer CR, Merrill BD, DeFelice BC, Sanchez JM, Higginbottom SK, Guthrie L, Fall LA, Dodd D, Fischbach MA, Sonnenburg JL. A metabolomics pipeline for the mechanistic interrogation of the gut microbiome. Nature. 2021;595(7867):415-20. PMID: 34262212 PMCID: PMC8939302 DOI: 10.1038/s41586-021-03707-9 6. Mitra S, Forster-Fromme K, Damms-Machado A, Scheurenbrand T, Biskup S, Huson DH, Bischoff SC. Analysis of the intestinal microbiota using SOLiD 16S rRNA gene sequencing and SOLiD shotgun sequencing. BMC Genomics. 2013;14 Suppl 5(Suppl 5):S16. PMID: 24564472 PMCID: PMC3852202 DOI: 10.1186/1471-2164-14-S5-S16 7. Huo L, Chen Q, Jia S, Zhang Y, Wang L, Li X, Li Z, Sun B, Shan J, Lin J, Yang L, Sui H. Gut microbiome promotes succinate-induced ulcerative colitis by enhancing glycolysis through SUCNR1/NF-kappaB signaling pathway. Am J Physiol Cell Physiol. 2025;329(2):C440-C54. PMID: 40549551 DOI: 10.1152/ajpcell.00411.2025 8. Tian S, Paudel D, Hao F, Neupane R, Castro R, Patterson AD, Tiwari AK, Prabhu KS, Singh V. Refined fiber inulin promotes inflammation-associated colon tumorigenesis by modulating microbial succinate production. Cancer Rep (Hoboken). 2023;6(11):e1863. PMID: 37489647 PMCID: PMC10644334 DOI: 10.1002/cnr2.1863 9. Haffke M, Fehlmann D, Rummel G, Boivineau J, Duckely M, Gommermann N, Cotesta S, Sirockin F, Freuler F, Littlewood-Evans A, Kaupmann K, Jaakola VP. Structural basis of species-selective antagonist binding to the succinate receptor. Nature. 2019;574(7779):581-5. PMID: 31645725 DOI: 10.1038/s41586-019-1663-8 10. Kim YI, Yi EJ, Kim YD, Lee AR, Chung J, Ha HC, Cho JM, Kim SR, Ko HJ, Cheon JH, Hong YR, Chang SY. Local Stabilization of Hypoxia-Inducible Factor-1alpha Controls Intestinal Inflammation via Enhanced Gut Barrier Function and Immune Regulation. Front Immunol. 2020;11:609689. PMID: 33519819 PMCID: PMC7840603 DOI: 10.3389/fimmu.2020.609689 11. Macias-Ceja DC, Ortiz-Masia D, Salvador P, Gisbert-Ferrandiz L, Hernandez C, Hausmann M, Rogler G, Esplugues JV, Hinojosa J, Alós R; Navarro F, Cosin-Roger J, Calatayud S, Barrachina MD. Succinate receptor mediates intestinal inflammation and fibrosis. Mucosal Immunol. 2019;12(1):178-87. PMID: 30279517 DOI: 10.1038/s41385-018-0087-3 "  [Collapse]
Boronat-Toscano A, Queipo-Ortuño MI, Monfort-Ferré D, Suau R, Vañó-Segarra I, Valldosera G, Cepero C, Astiarraga B, Clua-Ferré L, Plaza-Andrade I, Aranega-Martín L, Cabrinety L, Abadia de Barbarà C, Castellano-Castillo D, Moliné A, Caro A, Domènech E, Sánchez-Herrero JF, Benaiges-Fernandez R, Fernández-Veledo S, Vendrell J, Ginés I, Sumoy L, Manyé J, Menacho M, Serena C. Dialister-driven succinate accumulation is associated with disease activity and postoperative recurrence in Crohn’s disease. World J Gastroenterol 2025; 31(45): 112618
20
"This minireview systematically synthesizes the intricate interplay between depression and gastric cancer (GC), incorporating ..."  [Read more]
"This minireview systematically synthesizes the intricate interplay between depression and gastric cancer (GC), incorporating neuroendocrine, immunological, and psychosocial mechanisms. The authors effectively underscore the bidirectional causality supported by 52 referenced studies, in alignment with the biopsychosocial model. Nonetheless, there are opportunities to enhance methodological rigor and visual communication. Although Figure 1 delineates key components of the bidirectional relationship, its informational density is suboptimal. The figure lacks a hierarchical structuring of pathways (e.g., neuroendocrine versus immune mechanisms) and does not quantify effect sizes (e.g., hazard ratios from cited meta-analyses). It is recommended to incorporate a summary table for comparison. "  [Collapse]
Chen Z, Gong TJ, Zhao L. Bidirectional relationship between depression and the risk and prognosis of gastric cancer. World J Gastrointest Oncol 2025; 17(12): 113272
1134 items  Read more >>
Write to the Help Desk
  • ALL AUTHOR RESOURCES
  • Allegations of Misconduct
  • Appeals and Complaints
  • Article Processing Charge
  • Common Usage of Quantities and Units
  • Copyright License Agreement
  • Create an Account
  • Criteria for Authorship
  • Ethics Committee of BPG
  • Ethics Statements
  • Guidelines for Authors
  • Journals
  • Language Editing Process for Manuscripts Submitted by Non-Native Speakers of English
  • Methods of Post-Publication Debate
  • Open-Access
  • Publication Misconduct
  • Quality of Publications
  • Steps for Submitting Manuscripts
  • Submit a Manuscript
  • ALL PEER-REVIEWER RESOURCES
  • Manuscript Decision
  • Peer-Review Process
  • Peer-Reviewer Tracking for Manuscripts
  • Reviewer Acknowledgment
  • REFERENCE CITATION ANALYSIS
  • Find a Category
  • Find a Contributing Scholar
  • Find a Journal
  • Find an Academic Assistant
  • Find an Article
  • Find an Article PDF
  • Subscribe
  • Today's Articles
  • ALL PUBLISHER RESOURCES
  • About the BPG
  • BPG Home
  • Company Registration
  • Contact Us
  • ICMJE Conformity
  • Management Team
  • Membership
  • Ownership
  • Permissions
  • Privacy Policy
  • Publication Ethics
  • Publisher
  • Publishing Credentials
  • Revenue Sources
  • Special Statement
  • Terms of Use
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345